{"id":16970,"date":"2024-03-22T10:18:28","date_gmt":"2024-03-22T01:18:28","guid":{"rendered":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/?page_id=16970"},"modified":"2024-12-04T11:47:13","modified_gmt":"2024-12-04T02:47:13","slug":"results","status":"publish","type":"page","link":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/department\/center\/houshasen_center\/results\/","title":{"rendered":"\u653e\u5c04\u7dda\u6cbb\u7642\u79d1\/\u653e\u5c04\u7dda\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc \u81e8\u5e8a\u7814\u7a76\u767a\u8868\u5b9f\u7e3e"},"content":{"rendered":"\n

\u5e73\u621028\u5e74\u5ea6\uff5e\u4ee4\u548c5\u5e74\u5ea6<\/h2>\n\n\n\n

\u4ee4\u548c5\u5e74\u5ea6<\/h3>\n\n\n\n

\u3010\u8457\u66f8\u3011<\/p>\n\n\n\n

    \n
  1. \u5965\u6751\u654f\u4e4b\uff1a\u6d88\u5316\u5668\u816b\u760d\uff1a\u809d\u816b\u760d\u306b\u5bfe\u3059\u308b\u7c92\u5b50\u7dda\u6cbb\u7642\uff0e\u304c\u3093\u30fb\u653e\u5c04\u7dda\u7642\u6cd5\u6539\u8a02\u7b2c8\u7248\uff08\u5927\u897f\u6d0b\u3001\u5510\u6fa4\u4e45\u7f8e\u5b50\u3001\u897f\u5c3e\u798e\u6cbb\u3001\u77f3\u5ddd\u4ec1\u3000\u7de8\uff09Gakken\u3001p1033-1037\u30012023<\/li>\n<\/ol>\n\n\n\n

    \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

      \n
    1. Hiroshima Y\u3001Wakatsuki M\u3001Kaneko T\u3001Makishima H\u3001Okada NN\u3001Yasuda S\u3001Ishikawa H \u3001Tsuji H. Clinical impact of carbon-ion radiotherapy on hepatocellular carcinoma with Child-Pugh B cirrhosis. Cancer Med 12(13): 14004-14014\u30012023<\/li>\n\n\n\n
    2. Hiroshima Y\u3001Kondo M\u3001Sawada T\u3001 Hoshi SL\u3001Okubo R\u3001 Iizumi T\u3001Numajiri H\u3001Okumura T\u3001Sakurai H. Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan. Cancer Med 12(20): 20450-20458\u30012023<\/li>\n\n\n\n
    3. Hiroshima Y\u3001Kondo M\u3001Sawada T\u3001Hoshi S\u3001Okubo R\u3001lizumi T\u3001Numajiri H\u3001 Okumura T\u3001Sakurai H. PD-0083 Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer. Radioth Oncology 182: S47-S48\u30012023<\/li>\n\n\n\n
    4. Hiroshima Y\u3001Ishikawa H\u3001Sumiya T\u3001Murakami M\u3001Nakamura M\u3001Ishida T\u3001Ogawa K\u3001Hisakura K\u3001Mizumoto M\u3001Oda T\u3001Okumura T\u3001Sakurai H. Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal Cancer. In Vivo 37(3): 1253-1259\u30012023<\/li>\n\n\n\n
    5. Tokumaru S\u3001Ishikawa H\u3001Soejima T\u3001Kimoto T\u3001Takakusagi Y\u3001Tamamura H\u3001Wada H\u3001Taguchi H\u3001Uchinami Y\u3001Hiroshima Y\u3001Hojo H\u3001Kamei T\u3001Muto M\u3001Igeta M. Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer. J Radiat Res 64(Supplement_1): i16-i24\u30012023<\/li>\n\n\n\n
    6. Murayama S\u3001Yamada S\u3001Hiroshima Y\u3001Takiyama H\u3001Taguchi H\u3001Kimoto T\u3001Anzai M\u3001Hagiwara Y\u3001Yasui K\u3001Mori K\u3001Ishihara S\u3001Ueno H\u3001Shimizu S\u3001Aoyama H\u3001Tsuji H\u3001Sakurai H. Particle beam therapy for pelvic recurrence of colorectal cancer: a registry data analysis in Japan and a systematic review. J Radiat Res 64(Supplement_1): i25-i33\u30012023<\/li>\n\n\n\n
    7. Takizawa D\u3001Okumura T\u3001Mizumoto Y\u3001Nakai K\u3001 Sakurai H. A case of circumscribed choroidal hemangioma treated with proton beam therapy and followed up for 15 years. Cureus. 16(1): e52389. DOI 10.7759\/cureus.52389\u30012024<\/li>\n\n\n\n
    8. Nakamura M\u3001Ishikawa H\u3001Ohnishi K\u3001Baba K, Sumiya T\u3001Murakami M\u3001Hiroshima Y\u3001Mizumoto M\u3001Okumura T\u3001Sakurai H. Long-term outcomes after moderate hypofractionated proton therapy for centrally located non-small cell lung cancer. Anticancer Res\u300143: 2003-2013\u30012023<\/li>\n\n\n\n
    9. Saito T\u3001Murakami M\u3001Sumiya T\u3001Kobayashi D\u3001Shirataki H\u3001Fujioka D\u3001Baba K\u3001Itagaki H\u3001Tenjimbayashi Y\u3001Satoh T\u3001Sakurai H. Multimodal treatment with chemoradiotherapy, regional hyperthermia and interstitial brachytherapy for a huge locally advanced cervical cancer: A case report. Tech Innov Patient Support Radiat Oncol. 18;28:100222\u30012023<\/li>\n\n\n\n
    10. Oshiro Y\u3001Mizumoto M\u3001Miyamoto T\u3001Sumiya T\u3001Fujioka D\u3001Shirataki H\u3001Nakamura M\u3001Ishida T\u3001Iizumi T\u3001Saito T\u3001Numajiri H\u3001Makishima H\u3001Nakai K\u3001Maruo K\u3001Sakae T\u3001Sakurai H. Retrospective Analysis of the Areas Responsible for Light Flash and Odor During Proton Beam Therapy and Photon Therapy. Cureus. 6;15(9):e44790\u30012023<\/li>\n\n\n\n
    11. Doi Y\u3001Nagata Y\u3001Matsumoto Y\u3001Numata K\u3001Sasaki R\u3001Yamada T\u3001Igaki H\u3001Imagumbai T\u3001Katoh N\u3001Yoshitake T\u3001Shimizuguchi T\u3001Fujioka D\u3001Inoue M\u3001Koide Y\u3001Kimura T\u3001Ito Y. Multicenter retrospective study of stereotactic body radiotherapy for patients with previously untreated initial small hepatocellular carcinoma. Hepatol Res 53(8): 749-760\u3001 2023<\/li>\n\n\n\n
    12. Fuse H\u3001Tomita F\u3001Yasue K\u3001Ikoma H\u3001Miyakawa S\u3001Kori N\u3001Fujisaki T\u3001Ishimori Y\u3001 Monma M\u3001Okumura T\u3001Tamaki Y. Verification of dose distribution by different material properties in intraoral mold irradiation, Journal of Radiotherapy in Practice 22: 20\u30012023<\/li>\n\n\n\n
    13. Kito S\u3001Suda Y\u3001Tanabe S\u3001Takizawa T\u3001Nagahata T\u3001Tohyama N\u3001Okamoto H\u3001Kodama T\u3001Fujita Y\u3001Miyashita H\u3001Shinoda K\u3001Kurooka M\u3001Shimizu H\u3001Ohno T\u3001Sakamoto M. Radiological imaging protection: a study on imaging dose used while planning computed tomography for external radiotherapy in Japan. Journal of Radiation Research, 65(2): 159\u2013167\u30012024<\/li>\n\n\n\n
    14. Nakajima N\u3001Isobe T\u3001Furuyama Y\u3001Tomita T\u3001Kobayashi D\u3001Mori Y\u3001Takei H\u3001Nagai Y\u3001Ide Y\u3001Nemoto Murofushi K\u3001Nakajima M\u3001 Yoshioka Y. Analysis of source dwell position during treatment in brachytherapy using CT scout images. Journal of Contemporary Brachytherapy 15.5: 357-364\u30012023<\/li>\n\n\n\n
    15. \u5bcc\u7530\u53f2\u7d18\u3001\u5e03\u65bd\u62d3\u3001\u85e4\u5d0e\u9054\u4e5f\u3001\u5b89\u6c5f\u61b2\u6cbb\u3001\u5bae\u5ddd\u771f\u3001\u751f\u99d2\u82f1\u660e\u3001\u5409\u6ca2\u77e5\u884c\u3001\u5927\u5c71\u52dd\u5f66\u3001\u5927\u5c71\u54f2\u53f2\u3001\u5965\u6751\u654f\u4e4b\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u91d1\u5c5e\u304a\u3088\u3073\u6a39\u8102\u88fd\u30a2\u30d7\u30ea\u30b1\u30fc\u30bf\u3092\u7528\u3044\u305f\u5b50\u5bae\u9838\u304c\u3093\u8154\u5185\u7167\u5c04\u306b\u304a\u3051\u308b\u7dda\u91cf\u5206\u5e03\u306e\u691c\u8a3c\u3001\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u96d1\u8a8c\u300179 (7): 682-692\u30012023<\/li>\n<\/ol>\n\n\n\n

      \u4ee4\u548c4\u5e74\u5ea6<\/h3>\n\n\n\n

      \u3010\u539f\u8457\u3011<\/p>\n\n\n\n

        \n
      1. Terunuma T, Sakae T, Hu Y, Takei H, Moriya S, Okumura T, Sakurai H. Explainability and controllability of patient-specific deep learning with attention-based augmentation for markerless image-guided radiotherapy. Med Phys. 50(1):480-94, 2023.<\/li>\n\n\n\n
      2. Mizumoto M, Oshiro Y, Miyamoto T, Sumiya T, Shimizu S, Iizumi T, Saito T, Makishima H, Numajiri H, Nakai K, Okumura T, Sakae T, Maruo K, Sakurai H. Abnormal sensation during total body irradiation: a prospective observational study. J Radiat Res. 63(5):792-5, 2022.<\/li>\n\n\n\n
      3. Mizumoto M, Oshiro Y, Miyamoto T, Sumiya T, Baba K, Murakami M, Shimizu S, Iizumi T, Saito T, Makishima H, Numajiri H, Nakai K, Okumura T, Maruo K, Sakae T, Sakurai H. Light flash and odor during proton beam therapy for pediatric patients: a prospective observational study. Front Oncol. 12:863260, 2022.<\/li>\n\n\n\n
      4. Tony Liang H. K, Takei H, Tomita T, Terunuma T, Isobe T, Okumura T, Sakae T, Sakurai H. Analysis of diaphragm movements to specify geometric uncertainties of respiratory gating near end-exhalation for irradiation fields involving the liver dome. Radiother Oncol. 171:146-54, 2022.<\/li>\n\n\n\n
      5. Utsumi T, Suzuki H, Ishikawa H, Hiroshima Y, Wakatsuki M, Harada M, Ichikawa T, Akakura K and Tsuji H: External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort study. Jpn J Clin Oncol 52(8)<\/em>: 950-953, 2022. PMID: 35462397. DOI: 10.1093\/jjco\/hyac066<\/li>\n\n\n\n
      6. Nakamura M, Ishikawa H, Ohnishi K, Baba K, Saito T, Sumiya T, Murakami M, Hiroshima Y, Nakai K, Mizumoto M, Okumura T and Sakurai H: Proton Beam Therapy in Elderly Patients With cT1-3N0M0 Non-small Cell Lung Cancer. Anticancer Res 42(6)<\/em>: 2953-2960, 2022. PMID: 35641259. DOI: 10.21873\/anticanres.15778<\/li>\n\n\n\n
      7. Ishikawa H, Hiroshima Y, Kanematsu N, Inaniwa T, Shirai T, Imai R, Suzuki H, Akakura K, Wakatsuki M, Ichikawa T and Tsuji H: Carbon-ion radiotherapy for urological cancers. Int J Urol 29(10)<\/em>: 1109-1119, 2022. PMID: 35692124. DOI: 10.1111\/iju.14950<\/li>\n\n\n\n
      8. Hiroshima Y, Tamaki Y, Sawada T, Ishida T, Yasue K, Shinoda K, Saito T, Kaburagi T, Kiyoshima M, Okumura T and Sakurai H: Stereotactic Body Radiotherapy for Stage I Lung Cancer With a New Real-time Tumor Tracking System. Anticancer Res 42(6)<\/em>: 2989-2995, 2022. PMID: 35641279. DOI: 10.21873\/anticanres.15782<\/li>\n\n\n\n
      9. Hiroshima Y, Ishikawa H, Iwai Y, Wakatsuki M, Utsumi T, Suzuki H, Akakura K, Harada M, Sakurai H, Ichikawa T and Tsuji H: Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer. Cancers (Basel) 14(16)<\/em>, 2022. PMID: 36011007. DOI: 10.3390\/cancers14164015<\/li>\n\n\n\n
      10. Hiroshima Y, Tamaki Y, Sawada T, Murakami M, Ishida T, Saitoh T, Kojima H, Okumura T, Sakurai H. A Case Report of Radiotherapy for Skull Lesions of Langerhans Cell Histiocytosis With Dural Invasion. Cancer Diagn Progn. 3;2(2):258-262. doi: 10.21873\/cdp.10103. PMID: 35399171; PMCID: PMC8962801. 2022<\/li>\n\n\n\n
      11. Li Y, Mizumoto M, Oshiro Y, Nitta H, Saito T, Iizumi T, Kawano C, Yamaki Y, Fukushima H, Hosaka S, Maruo K, Kamizawa S, Sakurai H. A Retrospective Study of Renal Growth Changes after Proton Beam Therapy for Pediatric Malignant Tumor. Curr Oncol. 30(2):1560-70, 2023.<\/li>\n<\/ol>\n\n\n\n

        \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

          \n
        1. \u6fa4\u7530\u62d3\u54c9, \u8fd1\u85e4\u6b63\u82f1, \u9ad9\u6a4b\u745e\u5b63, \u5f8c\u85e4\u96c5\u660e, \u99ac\u5834\u656c\u4e00\u90ce, \u6751\u4e0a\u57fa\u5f18, \u77f3\u7530\u4fca\u6a39, \u4e2d\u6751\u96c5\u4fca, \u5ee3\u5d8b\u60a0\u4e00, \u98ef\u6cc9\u5929\u5fd7, \u95a2\u91ce\u96c4\u592a, \u52a0\u6cbc\u73b2\u5b50, \u7027\u6fa4\u5927\u5730, \u5927\u5ddd\u7dbe\u5b50, \u5927\u57ce\u4f73\u5b50, \u6c34\u672c\u6589\u5fd7, \u7389\u6728\u7fa9\u96c4, \u5965\u6751\u654f\u4e4b, \u6afb\u4e95\u82f1\u5e78: EQ-5D-5L\u306b\u3088\u308b\u80ba\u764c\u30fb\u98df\u9053\u764c\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306e\u6669\u671f\u6709\u5bb3\u4e8b\u8c61\u306eQOL\u5024.\u3000\u7b2c19\u56de\u8328\u57ce\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\uff0c2023.3\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
        2. \u65b0\u6d25\u5149, \u7389\u6728\u7fa9\u96c4, \u77f3\u7530\u4fca\u6a39, \u5ee3\u5d8b\u60a0\u4e00, \u52a0\u6cbc\u73b2\u5b50, \u6cb3\u5cf6\u901a\u4e45, \u7be0\u7530\u548c\u54c9, \u5965\u6751\u654f\u4e4b, \u6afb\u4e95\u82f1\u5e78: \u591a\u767a\u8133\u8ee2\u79fb\u306b\u5bfe\u3059\u308b\u30ea\u30cb\u30a2\u30c3\u30af\u30d9\u30fc\u30b9\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u521d\u671f\u7d4c\u9a13.\u3000\u7b2c36\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u3000\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\/\u7b2c7\u56de\u9ad8\u6a4b\u4fe1\u6b21\u8a18\u5ff5\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0c2023.3\uff08\u5343\u8449\uff09<\/li>\n\n\n\n
        3. \u65b0\u6d25\u5149, \u7389\u6728\u7fa9\u96c4, \u77f3\u7530\u4fca\u6a39, \u5ee3\u5d8b\u60a0\u4e00, \u52a0\u6cbc\u73b2\u5b50, \u5965\u6751\u654f\u4e4b, \u6afb\u4e95\u82f1\u5e78: \u591a\u767a\u8133\u8ee2\u79fb\u306b\u5bfe\u3059\u308b\u30ea\u30cb\u30a2\u30c3\u30af\u30d9\u30fc\u30b9\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u521d\u671f\u7d4c\u9a13. \u65e5\u672c\u91cf\u5b50\u533b\u79d1\u5b66\u4f1a\uff0c\u7b2c2\u56de\u5b66\u8853\u5927\u4f1a; 2022.12\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
        4. \u98ef\u6cc9\u5929\u5fd7, \u5965\u6751\u654f\u4e4b, \u89d2\u8c37\u6cf0\u8f14, \u77f3\u7530\u4fca\u6a39, \u6e05\u6c34\u7fd4\u661f, \u4e2d\u6751\u96c5\u4fca, \u95a2\u91ce\u96c4\u592a, \u658e\u85e4\u9ad8, \u7027\u6fa4\u5927\u5730, \u6cbc\u5c3b\u6674\u5b50, \u7267\u5cf6\u5f18\u548c, \u6c34\u672c\u6589\u5fd7, \u4e2d\u4e95\u5553, \u6afb\u4e95\u82f1\u5e78: \u816b\u760d\u5f84\uff15cm\u8d85\u306e\u5358\u767a\u809d\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u967d\u5b50\u7dda\u306e\u6cbb\u7642\u6210\u7e3e. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff0c2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
        5. \u4e2d\u6751\u96c5\u4fca, \u5927\u897f\u304b\u3088\u5b50, \u5965\u6751\u654f\u4e4b, \u89d2\u8c37\u6cf0\u8f14, \u77f3\u7530\u4fca\u6a39, \u98ef\u6cc9\u5929\u5fd7, \u658e\u85e4\u9ad8, \u6e05\u6c34\u7fd4\u661f, \u6cbc\u5c3b\u6674\u5b50, \u7267\u5cf6\u5f18\u548c, \u6c34\u672c\u6589\u5fd7, \u4e2d\u4e95\u5553, \u6afb\u4e95\u82f1\u5e78: \u7247\u80ba\u5168\u6458\u51fa\u8853\u5f8c\u306e\u80ba\u75c5\u5909\u306b\u5bfe\u3057\u6839\u6cbb\u7684\u967d\u5b50\u7dda\u6cbb\u7642\u3092\u65bd\u884c\u3057\u305f\uff14\u75c7\u4f8b\u306e\u691c\u8a0e. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff0c2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
        6. \u77f3\u7530\u4fca\u6a39, \u4e09\u6d66\u822a\u661f, \u5965\u6751\u654f\u4e4b, \u98ef\u6cc9\u5929\u5fd7, \u658e\u85e4\u9ad8, \u6e05\u6c34\u7fd4\u661f, \u6c34\u672c\u6589\u5fd7, \u6cbc\u5c3b\u6674\u5b50, \u7267\u5cf6\u5f18\u548c, \u4e2d\u4e95\u5553, \u6afb\u4e95\u82f1\u5e78: \u9ad8\u5ea6PVTT(Vp3,Vp4)\u3092\u4f34\u3046\u809d\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u967d\u5b50\u7dda\u6cbb\u7642\u306e\u9577\u671f\u81e8\u5e8a\u6210\u7e3e. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff0c2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
        7. \u65b0\u6d25\u5149, \u77f3\u7530\u4fca\u6a39, \u5ee3\u5d8b\u60a0\u4e00, \u52a0\u6cbc\u73b2\u5b50, \u5965\u6751\u654f\u4e4b, \u7389\u6728\u7fa9\u96c4: \u591a\u767a\u8133\u8ee2\u79fb\u306b\u5bfe\u3059\u308b\u30ea\u30cb\u30a2\u30c3\u30af\u30d9\u30fc\u30b9\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u521d\u671f\u7d4c\u9a13. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff0c2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
        8. \u6e05\u6c34\u7fd4\u661f, \u5965\u6751\u654f\u4e4b, \u6751\u4e0a\u57fa\u5f18, \u99ac\u5834\u656c\u4e00\u90ce, \u4e2d\u6751\u96c5\u4fca, \u5ee3\u5d8b\u60a0\u4e00, \u98ef\u6cc9\u5929\u5fd7, \u658e\u85e4\u9ad8, \u6cbc\u5c3b\u6674\u5b50, \u7267\u5cf6\u5f18\u548c, \u6c34\u672c\u6589\u5fd7, \u4e2d\u4e95\u5553, \u6afb\u4e95\u82f1\u5e78: \u5207\u9664\u4e0d\u80fd\u521d\u767a\u809d\u5185\u80c6\u7ba1\u764c\u306b\u5bfe\u3059\u308b\u967d\u5b50\u7dda\u6cbb\u7642\u306e\u6210\u7e3e\u306e\u89e3\u6790. \u7b2c31\u56de\u65e5\u672c\u764c\u75c5\u614b\u6cbb\u7642\u7814\u7a76\u4f1a\uff0c2022.6\uff08\u5fb3\u5cf6\uff09<\/li>\n\n\n\n
        9. \u98ef\u6cc9\u5929\u5fd7, \u9ad8\u6a4b\u745e\u5b63, \u99ac\u5834\u656c\u4e00\u90ce, \u6751\u4e0a\u57fa\u5f18, \u6e05\u6c34\u7fd4\u661f, \u658e\u85e4\u9ad8, \u7267\u5cf6\u5f18\u548c, \u6cbc\u5c3b\u6674\u5b50, \u6c34\u672c\u6589\u5fd7, \u4e2d\u4e95\u5553, \u5965\u6751\u654f\u4e4b, \u6afb\u4e95\u82f1\u5e78: \u9ad8\u9f62\u8005\u521d\u767a\u809d\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u967d\u5b50\u7dda\u6cbb\u7642\u60a3\u8005\u306e\u6cbb\u7642\u524d\u30b3\u30ea\u30f3\u30a8\u30b9\u30c6\u30e9\u30fc\u30bc\u5024\u3068\u4e88\u5f8c\u4e88\u6e2c\u3068\u306e\u95a2\u9023. \u7b2c27\u56de\u764c\u6cbb\u7642\u5897\u611f\u7814\u7a76\u4f1a\uff08IASCT27\uff09\uff0c2022.4\uff08\u5927\u6d17\uff09<\/li>\n\n\n\n
        10. Iizumi T, Okumura T, Maruo K, Baba K, Murakami M, Shimizu S, Saito T, Numajiri H, Makishima H, Mizumoto M, Nakai K, Sakurai H: Long-term outcome of the oldest-old patient (85 years or older) underwent proton beam therapy for hepatocellular carcinoma. The 31th Conference of the Asian Pacific Association for the Study of the Liver; 2022.3 \uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
        11. Hiroshima Y, Wakatsuki M, Kaneko T, Makishima H, Ishikawa H, Tsuji H\u3000Clinical impact of carbon ion radiotherapy for hepatocellular carcinoma with Child-Pugh B cirrhosis\u3000ESTRO2022\u30002022.5\u3000\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
        12. \u5ee3\u5d8b \u60a0\u4e00\u3001\u82e5\u6708 \u512a\u3001\u91d1\u5b50 \u5d07\u3001\u7267\u5cf6 \u5f18\u548c\u3001\u77f3\u5ddd \u4ec1\u3001\u8fbb \u6bd4\u5442\u5fd7\u3000Child-Pugh\u5206\u985eB\u3092\u80cc\u666f\u809d\u3068\u3059\u308b\u3001\u809d\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u306e\u6cbb\u7642\u6210\u7e3e\u3068\u6bd2\u6027\u3000\u7b2c58\u56de\u65e5\u672c\u809d\u764c\u7814\u7a76\u4f1a\u30002022.5\u3000\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
        13. \u5ee3\u5d8b \u60a0\u4e00\u3001\u798f\u5149 \u5ef6\u5409\u3001\u6e05\u6c34 \u7fd4\u661f\u3001\u77f3\u7530 \u4fca\u6a39\u3001\u4e2d\u6751 \u96c5\u4fca\u3001\u98ef\u6cc9 \u5929\u5fd7\u3001\u658e\u85e4 \u9ad8\u3001 \u6cbc\u5c3b \u6674\u5b50\u3001\u6c34\u672c \u6589\u5fd7\u3001\u4e2d\u4e95 \u5553\u3001\u5965\u6751 \u654f\u4e4b\u3001\u6afb\u4e95 \u82f1\u5e78\u3000\u5207\u9664\u4e0d\u80fd\u30fb\u5c40\u6240\u9032\u884c\u81b5\u764c\u306b\u5bfe\u3059\u308b\u6e29\u71b1\u7642\u6cd5\u4f75\u7528\u5316\u5b66\u967d\u5b50\u7dda\u30fbX \u7dda\u6cbb\u7642\u306e\u6cbb\u7642\u6210\u7e3e\u3068\u6bd2\u6027\u306e\u691c\u8a0e\u3000\u7b2c31\u56de\u65e5\u672c\u764c\u75c5\u614b\u6cbb\u7642\u7814\u7a76\u4f1a\u30002022.6\u3000\uff08\u5fb3\u5cf6\uff09<\/li>\n\n\n\n
        14. \u5ee3\u5d8b \u60a0\u4e00\u3001\u77f3\u5ddd \u4ec1\u3001\u89d2\u8c37 \u6cf0\u8f14\u3001\u6751\u4e0a \u57fa\u5f18\u3001\u4e2d\u6751 \u96c5\u4fca\u3001\u98ef\u6cc9 \u5929\u5fd7\u3001\u5965\u6751 \u654f\u4e4b\u3001\u6afb\u4e95 \u82f1\u5e78\u3000\u98df\u9053\u764c\u6839\u6cbb\u8853\u5f8c\u518d\u767a\u306b\u5bfe\u3059\u308b\u967d\u5b50\u7dda\u6cbb\u7642\u306e\u6cbb\u7642\u6210\u7e3e\u3068\u6bd2\u6027\u306e\u691c\u8a0e\u3000\u7b2c76\u56de\u65e5\u672c\u98df\u9053\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30002022.9\u3000\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
        15. Hiroshima Y, Ishikawa H, Utsumi T, Wakatsuki M, Akakura K,  Suzuki H, Tsuji H\u3000Efficacy and safety of carbon-ion radiotherapy in elderly prostate cancer patients\u3000\u7b2c60\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002022.10\u3000\uff08\u6a2a\u6d5c\uff09<\/li>\n\n\n\n
        16. \u5ee3\u5d8b \u60a0\u4e00, \u77f3\u5ddd \u4ec1, \u6751\u4e0a \u57fa\u5f18, \u68ee \u5eb7\u6676\u3001\u9752\u6728 \u79c0\u68a8\u3001\u4e2d\u5d8b \u7f8e\u7dd2\u3001\u82e5\u6708 \u512a\u3001\u5185\u6d77 \u5b5d\u4fe1\u3001\u9234\u6728 \u5553\u60a6\u3001\u8d64\u5009 \u529f\u4e00\u90ce\u3001\u8fbb \u6bd4\u5442\u5fd7\u3001\u5c71\u7530 \u6ecb\u3000\u524d\u7acb\u817a\u764c\u9ad8\u30ea\u30b9\u30af\u7fa4\u306e\u9ad8\u9f62\u60a3\u8005\u306b\u5bfe\u3059\u308b\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u306e\u6cbb\u7642\u6210\u7e3e\u3000\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\u30002022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
        17. \u658e\u85e4\u9ad8, \u6751\u4e0a\u57fa\u5f18, \u89d2\u8c37\u6cf0\u8f14, \u85e4\u5ca1\u4f1d, \u65b0\u6d25\u5149, \u5f8c\u85e4\u96c5\u660e, \u5c0f\u6797\u5927\u8f14, \u5bcc\u7530\u54f2\u4e5f, \u6cbc\u5c3b\u6674\u5b50, \u6afb\u4e95\u82f1\u5e78: \u5de8\u5927\u5c40\u6240\u9032\u884c\u5b50\u5bae\u9838\u764c\u306b\u5bfe\u3057\u3066\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u3068\u7d44\u7e54\u5185\u7167\u5c04\u3092\u4f75\u7528\u3057\u305f\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u304c\u594f\u529f\u3057\u305f1\u4f8b.  \u95a2\u6771\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u7814\u7a76\u4f1a\u3000\u7b2c24\u56de\u95a2\u6771\u30fb\u5168\u8eab\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u7814\u7a76\u4f1a\u5408\u540c\u5b66\u8853\u7814\u7a76\u4f1a\uff0c2023.3\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
        18. \u5f8c\u85e4\u96c5\u660e, \u98ef\u6cc9\u5929\u5fd7, \u658e\u85e4\u9ad8, \u77f3\u7530\u4fca\u6a39, \u89d2\u8c37\u6cf0\u8f14, \u65b0\u6d25\u5149, \u85e4\u5ca1\u4f1d, \u4e2d\u4e95\u5553, \u6afb\u4e95\u82f1\u5e78: \u524d\u7acb\u817a\u304c\u3093\u967d\u5b50\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u30cf\u30a4\u30c9\u30ed\u30b2\u30eb\u76f4\u8178\u5468\u56f2\u30b9\u30da\u30fc\u30b5\u30fc\u7559\u7f6e\u306e\u521d\u671f\u7d4c\u9a13. \u7b2c36\u56de\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u3000\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\/\u7b2c7\u56de\u9ad8\u6a4b\u4fe1\u6b21\u8a18\u5ff5\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0c2023.3\uff08\u5343\u8449\uff09<\/li>\n\n\n\n
        19. \u65b0\u7530\u8449\u6708, \u6c34\u672c\u6589\u5fd7, \u674e\u5b9c\u8afe, \u89d2\u8c37\u6cf0\u8f14, \u77f3\u7530\u4fca\u6a39, \u4e2d\u6751\u96c5\u4fca, \u6e05\u6c34\u7fd4\u661f, \u98ef\u6cc9\u5929\u5fd7, \u658e\u85e4\u9ad8, \u7267\u5cf6\u5f18\u548c, \u6cbc\u5c3b\u6674\u5b50, \u4e2d\u4e95\u5553, \u6afb\u4e95\u82f1\u5e78: \u5c0f\u5150\u816b\u760d\u306b\u5bfe\u3059\u308b\u967d\u5b50\u7dda\u6cbb\u7642\u5f8c\u306e\u8edf\u90e8\u7d44\u7e54\u6210\u9577\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff0c2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
        20. \u85e4\u5ca1\u4f1d, \u89d2\u8c37\u6cf0\u8f14, \u658e\u85e4\u9ad8, \u77f3\u7530\u4fca\u6a39, \u6e05\u6c34\u7fd4\u661f, \u4e2d\u6751\u96c5\u4fca, \u98ef\u6cc9\u5929\u5fd7, \u7267\u5cf6\u5f18\u548c, \u6cbc\u5c3b\u6674\u5b50, \u6c34\u672c\u6589\u5fd7, \u4e2d\u4e95\u5553, \u6afb\u4e95\u82f1\u5e78: \u8179\u58c1\u9032\u5c55\u3092\u4f34\u3046\u5de8\u5927\u306a\u5207\u9664\u4e0d\u80fd\u5916\u9670\u764c\u306b\u5bfe\u3057\u3066\u7d44\u7e54\u5185\u7167\u5c04\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff0c2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
        21. \u5f8c\u85e4\u96c5\u660e, \u6e05\u6c34\u7fd4\u661f, \u98ef\u6cc9\u5929\u5fd7, \u658e\u85e4\u9ad8, \u77f3\u7530\u4fca\u6a39, \u89d2\u8c37\u6cf0\u8f14, \u85e4\u5ca1\u4f1d, \u4e2d\u6751\u96c5\u4fca, \u6cbc\u5c3b\u6674\u5b50, \u7267\u5cf6\u5f18\u548c, \u4e2d\u4e95\u5553, \u6c34\u672c\u6589\u5fd7, \u6afb\u4e95\u82f1\u5e78: \u30cf\u30a4\u30c9\u30ed\u30b2\u30eb\u76f4\u8178\u5468\u56f2\u30b9\u30da\u30fc\u30b5\u30fc\u7559\u7f6e\u5f8c\u306b\u8840\u6813\u6027\u9759\u8108\u708e\u3092\u5448\u3057\u305f\uff11\u4f8b. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff0c2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
        22. \u89d2\u8c37\u6cf0\u8f14, \u658e\u85e4\u9ad8, \u85e4\u5ca1\u4f1d, \u5f8c\u85e4\u96c5\u660e, \u77f3\u7530\u4fca\u6a39, \u6e05\u6c34\u7fd4\u661f, \u4e2d\u6751\u96c5\u4fca, \u98ef\u6cc9\u5929\u5fd7, \u6cbc\u5c3b\u6674\u5b50, \u7267\u5cf6\u5f18\u548c, \u4e2d\u4e95\u5553, \u6c34\u672c\u6589\u5fd7, \u6afb\u4e95\u82f1\u5e78: \u60aa\u6027\u8ee2\u5316\u3092\u4f34\u3046\u6210\u719f\u56a2\u80de\u6027\u5947\u5f62\u816b\u306b\u5bfe\u3059\u308b\u8853\u5f8c\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306e\u6210\u7e3e. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff0c2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
        23. \u6d45\u91ce\u60a0\u6597, \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300e\u5de6\u4e73\u304c\u3093\u6df1\u5438\u6c17\u606f\u6b62\u3081\u7167\u5c04\u306b\u304a\u3051\u308b\u547c\u5438\u6027\u79fb\u52d5\u5bfe\u7b56\u306e\u904b\u7528\u65b9\u6cd5\u300f\u300c\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308bDIBH\u306e\u904b\u7528\u65b9\u6cd5\u300d\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u3000\u7b2c69\u56de\u3000\u95a2\u6771\u652f\u90e8\u7814\u7a76\u767a\u8868\u5927\u4f1a2022.12\uff08\u3064\u304f\u3070\uff09<\/li>\n<\/ol>\n\n\n\n

          \u3010\u53d7\u8cde\u3011<\/p>\n\n\n\n

            \n
          1. \u85e4\u5ca1\u4f1d, \u89d2\u8c37\u6cf0\u8f14, \u658e\u85e4\u9ad8, \u77f3\u7530\u4fca\u6a39, \u6e05\u6c34\u7fd4\u661f, \u4e2d\u6751\u96c5\u4fca, \u98ef\u6cc9\u5929\u5fd7, \u7267\u5cf6\u5f18\u548c, \u6cbc\u5c3b\u6674\u5b50, \u6c34\u672c\u6589\u5fd7, \u4e2d\u4e95\u5553, \u6afb\u4e95\u82f1\u5e78: \u8179\u58c1\u9032\u5c55\u3092\u4f34\u3046\u5de8\u5927\u306a\u5207\u9664\u4e0d\u80fd\u5916\u9670\u764c\u306b\u5bfe\u3057\u3066\u7d44\u7e54\u5185\u7167\u5c04\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c35\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u512a\u79c0\u6f14\u984c\u8cde2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n\n\n\n
          2. \u6fa4\u7530\u62d3\u54c9, \u8fd1\u85e4\u6b63\u82f1, \u9ad9\u6a4b\u745e\u5b63, \u5f8c\u85e4\u96c5\u660e, \u99ac\u5834\u656c\u4e00\u90ce, \u6751\u4e0a\u57fa\u5f18, \u77f3\u7530\u4fca\u6a39, \u4e2d\u6751\u96c5\u4fca, \u5ee3\u5d8b\u60a0\u4e00, \u98ef\u6cc9\u5929\u5fd7, \u95a2\u91ce\u96c4\u592a, \u52a0\u6cbc\u73b2\u5b50, \u7027\u6fa4\u5927\u5730, \u5927\u5ddd\u7dbe\u5b50, \u5927\u57ce\u4f73\u5b50, \u6c34\u672c\u6589\u5fd7, \u7389\u6728\u7fa9\u96c4, \u5965\u6751\u654f\u4e4b, \u6afb\u4e95\u82f1\u5e78: EQ-5D-5L\u306b\u3088\u308b\u80ba\u764c\u30fb\u98df\u9053\u764c\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306e\u6669\u671f\u6709\u5bb3\u4e8b\u8c61\u306eQOL\u5024. \u7b2c19\u56de\u8328\u57ce\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\uff0c\u512a\u79c0\u6f14\u984c\u8cde2023.3\uff08\u3064\u304f\u3070\uff09<\/li>\n<\/ol>\n\n\n\n

            \u3010\u5ea7\u9577\u3011<\/p>\n\n\n\n

              \n
            1. \u5965\u6751\u654f\u4e4b\u3000\u653e\u5c04\u7dda\u6cbb\u76422\uff0c\u7b2c58\u56de\u65e5\u672c\u809d\u764c\u7814\u7a76\u4f1a2022.5\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
            2. \u5965\u6751\u654f\u4e4b\u3000\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\u300c\u7b51\u6ce2\u5927\u5b66\u306b\u304a\u3051\u308bBNCT\u81e8\u5e8a\u7814\u7a76\u4eca\u6614\u300d\u7b2c18\u56de\u65e5\u672c\u4e2d\u6027\u5b50\u6355\u6349\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a 2022.10\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
            3. \u5965\u6751\u654f\u4e4b\u3000\u8981\u671b\u6f14\u984c\u30fb\u809d\u81d3\u764c\uff0c\u7b2c35\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a 2022.11\uff08\u5e83\u5cf6\uff09<\/li>\n<\/ol>\n\n\n\n

              \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                \n
              1. \u7be0\u7530\u548c\u54c9\u3001\u300c\u52a0\u901f\u7ba1\u306e\u69cb\u9020\u3068\u95a2\u9023\u3059\u308b\u6545\u969c\u306b\u3064\u3044\u3066\u300d\u7b2c78\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a\u5c02\u9580\u90e8\u4f1a\u8b1b\u5ea7\u5c02\u9580\u7de8\u30012022.4\uff08\u6a2a\u6d5c\uff09<\/li>\n\n\n\n
              2. \u7be0\u7530\u548c\u54c9\u3001\u300c\u52a0\u901f\u7ba1\u306e\u69cb\u9020\u3068\u95a2\u9023\u3059\u308b\u6545\u969c\u306b\u3064\u3044\u3066\u300d\u7b2c60\u56de\u5343\u8449\u770c\u653e\u5c04\u7dda\u6cbb\u7642\u8b1b\u6f14\u4f1a\u30012022.9\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n<\/ol>\n\n\n\n

                \u3010\u8b1b\u7fa9\u3011<\/p>\n\n\n\n

                  \n
                1. \u5ee3\u5d8b\u60a0\u4e00,\u3000\u75c5\u7406\u5b66I\u3000\u653e\u5c04\u7dda\u7dcf\u8ad6\u3000\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u770b\u8b77\u5c02\u9580\u5b66\u6821 2\u5e74\u8ab2\u7a0b1\u5e74\u6b212022.6<\/li>\n\n\n\n
                2. \u5ee3\u5d8b\u60a0\u4e00,\u3000\u75c5\u7406\u5b66I\u3000\u653e\u5c04\u7dda\u6cbb\u7642\u3000\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u770b\u8b77\u5c02\u9580\u5b66\u6821 2\u5e74\u8ab2\u7a0b1\u5e74\u6b212022.6<\/li>\n\n\n\n
                3. \u5965\u6751\u654f\u4e4b,  \u75c5\u7406\u5b66I  \u653e\u5c04\u7dda\u8a3a\u65ad\u3000\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u770b\u8b77\u5c02\u9580\u5b66\u6821 2\u5e74\u8ab2\u7a0b1\u5e74\u6b212022.6<\/li>\n\n\n\n
                4. \u76f8\u6fa4\u5065\u592a\u90ce\uff0e\u30ea\u30b9\u30af\u7ba1\u7406\u8ad6\uff0e\u8328\u57ce\u770c\u7acb\u533b\u7642\u5927\u5b66\u3001\u653e\u5c04\u7dda\u6280\u8853\u79d1\u5b66\u79d1\u30004\u5e74\u6b212022.7<\/li>\n\n\n\n
                5. \u76f8\u6fa4\u5065\u592a\u90ce\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u30ea\u30b9\u30af\u7ba1\u7406\u30fb\u30b1\u30a2\uff0e\u8328\u57ce\u770c\u7acb\u533b\u7642\u5927\u5b66\u3001\u653e\u5c04\u7dda\u6280\u8853\u79d1\u5b66\u79d1\u30004\u5e74\u6b212022.7<\/li>\n\n\n\n
                6. \u5965\u6751\u654f\u4e4b,  \u6cbb\u7642\u8ad6\u3000\u653e\u5c04\u7dda\u7642\u6cd5\u3000\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u770b\u8b77\u5c02\u9580\u5b66\u6821  3\u5e74\u8ab2\u7a0b1\u5e74\u6b21 2022.10<\/li>\n\n\n\n
                7. \u5965\u6751\u654f\u4e4b\uff0c\u6cbb\u7642\u5b66\u7dcf\u8ad6\u30fb\u96c6\u5b66\u7684\u6cbb\u7642\u3000\u7b51\u6ce2\u5927\u5b66\u533b\u5b66\u5c02\u9580\u5b66\u7fa4 4\u5e74\u6b21\u30002022.12<\/li>\n<\/ol>\n\n\n\n

                  \u4ee4\u548c3\u5e74\u5ea6<\/h3>\n\n\n\n

                  \u3010\u539f\u8457\u3011<\/p>\n\n\n\n

                    \n
                  1. Oshiro Y, Mizumoto M, Sekino Y, Maruo K, Ishida T, Sumiya T, Nakamura M, Ohkawa A, Takizawa D, Okumura T, Tamaki Y, Sakurai H. Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi- institutional research in Japan. Clin Transl Radiat Oncol\u3001 29;29:54-59. doi: 10.1016\/j.ctro.2021.05.009. PMID: 34151033; PMCID: PMC8190008. 2021<\/li>\n\n\n\n
                  2. Yasue K, Fuse H, Oyama S, Hanada K, Shinoda K, Ikoma H, Fujisaki T, Tamaki Y. Quantitative analysis of the intra-beam respiratory motion with baseline drift for respiratory-gating lung stereotactic body radiation therapy. J Radiat Res. 20;63(1):137-147. doi: 10.1093\/jrr\/rrab098. PMID: 34718704; PMCID: PMC8776700. 2022<\/li>\n\n\n\n
                  3. Yasue K, Fuse H, Asano Y, Kato M, Shinoda K, Ikoma H, Fujisaki T, Tamaki Y. Investigation of fiducial marker recognition possibility by water equivalent length in real-time tracking radiotherapy. Jpn J Radiol. 40(3):318-325. doi: 10.1007\/s11604-021-01207-4. Epub 2021 Oct 16.PMID: 34655387. 2022<\/li>\n\n\n\n
                  4. Goto M, Oshiro Y, Tamaki Y, Ishida T, Kato Y, Shinoda K, Sakurai H. A novel method for skin marking in radiotherapy: first clinical use of temporary organic tattoo seal. J Radiat Res. 17;63(2):314-318. doi: 10.1093\/jrr\/rrab126. PMID: 35067716; PMCID: PMC8944313. 2022<\/li>\n\n\n\n
                  5. Ishida T, Ohno T, Saito T, Hiroshima Y, Akito S, Tatsuo I, Yoshida A, Mizumoto M, Sakurai H, Tamaki Y. A Recurrent Solitary Fibrous Tumor With an Exceptional Response to Low-Dose Radiotherapy: A Case Report and Literature Review. Cureus. 13;14(1):e21199. doi: 10.7759\/cureus.21199. PMID: 35186518; PMCID: PMC8844230. 2022<\/li>\n\n\n\n
                  6. Hiroshima Y, Tamaki Y, Sawada T, Murakami M, Ishida T, Saitoh T, Kojima H, Okumura T, Sakurai H. A Case Report of Radiotherapy for Skull Lesions of Langerhans Cell Histiocytosis With Dural Invasion. Cancer Diagn Progn. 3;2(2):258-262. doi: 10.21873\/cdp.10103. PMID: 35399171; PMCID: PMC8962801. 2022<\/li>\n\n\n\n
                  7. \u7be0\u7530\u548c\u54c9\uff1a \u533b\u5b66\u7269\u7406\u58eb\u306e\u4ed5\u4e8b.\u65e5\u672c\u533b\u5b66\u7269\u7406\u58eb\u4f1a\u4f1a\u5831\u7b2c48\u53f7. 2021<\/li>\n<\/ol>\n\n\n\n

                    \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

                      \n
                    1. \u5f8c\u85e4\u96c5\u660e\u3001\u4e8c\u6751\u4fdd\u5fb3\u3001\u658e\u85e4\u3000\u9ad8\u3001\u77f3\u7530\u4fca\u6a39\u3001\u7389\u6728\u3000\u7fa9\u96c4\uff0c\u6afb\u4e95\u9244\u4e5f\u3001\u6afb\u4e95\u82f1\u5e78. \u6a5f\u68b0\u5b66\u7fd2\u3092\u7528\u3044\u305f\u5b50\u5bae\u9838\u304c\u3093\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306e\u4e88\u5f8c\u4e88\u6e2c.\u3000\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c34\u56de\u5b66\u8853\u5927\u4f1a\u30012021.11.12\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                    2. \u5f8c\u85e4\u96c5\u660e\u3001\u7be0\u7530\u548c\u54c9\u3001\u52a0\u85e4\u96c4\u4e00\u3001\u5b8d\u5009\u512a\u5b50\u3001\u5c0f\u6cc9\u7dbe\u9999\u3001\u77f3\u7530\u4fca\u6a39\u3001\u6fa4\u7530\u62d3\u54c9\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5927\u57ce\u4f73\u5b50\u3001\u6afb\u4e95\u82f1\u5e78\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u65b0\u3057\u3044\u76ae\u819a\u30de\u30fc\u30ad\u30f3\u30b0Inkbox\u306e\u521d\u671f\u4f7f\u7528\u8a55\u4fa1\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c34\u56de\u5b66\u8853\u5927\u4f1a\u30012021.11.12\u3000\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                    3. \u6fa4\u7530\u62d3\u54c9\uff0c\u7389\u6728\u7fa9\u96c4\uff0c\u77f3\u7530\u4fca\u6a39\uff0c\u52a0\u6cbc\u73b2\u5b50\uff0c\u9f4a\u85e4\u3000\u9ad8\uff0e\u9650\u5c40\u578b\u5c0f\u7d30\u80de\u80ba\u764c\u306e\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u304a\u3051\u308bG-CSF\u88fd\u5264\u4f7f\u7528\u306e\u5f8c\u65b9\u8996\u7684\u691c\u8a0e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c34\u56de\u5b66\u8853\u5927\u4f1a\u30012021.11.12\u3000\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                    4. \u65b0\u6d25\u3000\u5149\u3001\u77f3\u7530\u4fca\u6a39\u3001\u52a0\u6cbc\u73b2\u5b50\u3001\u658e\u85e4\u3000\u9ad8\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u3092\u65bd\u884c\u3057\u305fMerkel\u7d30\u80de\u764c\u306e4\u4f8b\uff0e\u7b2c458\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30012022.2.26\u3000\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                    5. \u6fa4\u7530\u62d3\u54c9\u3001\u8fd1\u85e4\u6b63\u82f1\u3001\u99ac\u5834\u656c\u4e00\u90ce\u3001\u6751\u4e0a\u57fa\u5f18\u3001\u77f3\u7530\u4fca\u6a39\u3001\u4e2d\u6751\u96c5\u4fca\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u98ef\u6cc9\u5929\u5fd7\u3001\u3001\u95a2\u91ce\u96c4\u592a\u3001\u5927\u5ddd\u7dbe\u5b50\u3001\u5927\u57ce\u4f73\u5b50\u3001\u6c34\u672c\u6589\u5fd7\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5965\u6751\u654f\u4e4b\u3001\u6afb\u4e95\u82f1\u5e78\uff0eEQ-5D-5L\u306b\u3088\u308b\u80ba\u30fb\u98df\u9053\u764c\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306e\u6669\u671f\u6709\u5bb3\u4e8b\u8c61\u306eQOL\u5024\uff0e\u7b2c92\u56de\u65e5\u672c\u885b\u751f\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30012022.3.21\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                    6. \u7be0\u7530\u548c\u54c9\uff0e\u30ce\u30f3\u30b3\u30d7\u30e9\u30ca\u30fc\u7167\u5c04\u6cd5\u306b\u3064\u3044\u3066\u6539\u3081\u3066\u8003\u3048\u308b-BrainLab\u793e\u88fdMultiple Brain Mets SRS-\uff0e\u798f\u5cf6\u770c\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a(Advance). 2021.4.24\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                    7. \u7be0\u7530\u548c\u54c9. \u52d5\u4f53\u8ffd\u5c3e\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u5b9f\u969b\uff0e\u81e8\u5e8a\u533b\u5b66\u7269\u7406\u7814\u7a76\u4f1a\u7b2c61\u56de\u5b9a\u4f8b\u4f1a. 2022.2.1\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n<\/ol>\n\n\n\n

                      \u3010\u5ea7\u9577\u3011<\/p>\n\n\n\n

                        \n
                      1. \u7389\u6728\u7fa9\u96c4\u3000\u9ad8\u9f62\u8005\u80ba\u764c\u8a3a\u7642\u3092\u8003\u3048\u308b\u4f1ain\u7b20\u9593\u30002021.7.7\u3000\uff08\u7b20\u9593\uff09<\/li>\n<\/ol>\n\n\n\n

                        \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                          \n
                        1. \u7389\u6728\u7fa9\u96c4\uff0e\u80ba\u764c\u306e\u653e\u5c04\u7dda\u8a3a\u7642\uff0e\u4ee4\u548c3\u5e74\u5ea6\u304c\u3093\u770c\u6c11\u516c\u958b\u30bb\u30df\u30ca\u30fc\u300c\u529b\u3092\u5408\u308f\u305b\u308b\u80ba\u304c\u3093\u8a3a\u7642\u300d\u3001\u30002021.10.30\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                        2. \u77f3\u7530\u4fca\u6a39\uff0e\u80ba\u764c\u306e\u653e\u5c04\u7dda\u6cbb\u7642\uff0e\u7b2c117\u56de \u7b20\u9593\u5e02\u533b\u5e2b\u4f1a\u80f8\u90e8\u75be\u60a3\u691c\u8a0e\u4f1a\uff0e2021.12.8\uff08\u7b20\u9593\uff09\u3000<\/li>\n\n\n\n
                        3. \u7389\u6728\u7fa9\u96c4\uff0e\u5f53\u9662\u306b\u304a\u3051\u308b\u8ee2\u79fb\u6027\u8133\u816b\u760d\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u73fe\u72b6\uff0e\u4ee4\u548c3\u5e74\u5ea6\u304c\u3093\u8a3a\u7642\u9023\u643a\u62e0\u70b9\u75c5\u9662\u6a5f\u80fd\u5f37\u5316\u4e8b\u696d\u306b\u304a\u3051\u308b\u304c\u3093\u533b\u7642\u5f93\u4e8b\u8005\u7814\u4fee\u4f1a\uff0e2022.3.23\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                        4. \u7be0\u7530\u548c\u54c9\uff0e\u8133\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u6280\u8853\u89e3\u8aac\uff0e\u4ee4\u548c\uff13\u5e74\u5ea6\u8328\u57ce\u770c\u304c\u3093\u8a3a\u7642\u62e0\u70b9\u75c5\u9662\u533b\u7642\u5f93\u4e8b\u8005\u7814\u4fee\u4f1a. 2022.3.23. \uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                        5. \u7be0\u7530\u548c\u54c9. \u3010\u8b1b\u7fa9\uff18\u3011\u5404\u7167\u5c04\u6280\u6cd5\u306e\u30d7\u30e9\u30f3\u30cb\u30f3\u30b0\u4f5c\u6210\u624b\u9806\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u95a2\u6771\u652f\u90e8\u95a2\u6771RT\u7814\u7a76\u4f1a\u30df\u30cb\u8b1b\u7fd2\u4f1a. 2021.11.20\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                        6. \u7be0\u7530\u548c\u54c9. \u52d5\u4f53\u8ffd\u5c3e\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u5b9f\u969b\uff0e\u81e8\u5e8a\u533b\u5b66\u7269\u7406\u7814\u7a76\u4f1a\u7b2c61\u56de\u5b9a\u4f8b\u4f1a. 2022.2.1.\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n<\/ol>\n\n\n\n

                          \u3010\u8b1b\u7fa9\u3011<\/p>\n\n\n\n

                            \n
                          1. \u76f8\u6fa4\u5065\u592a\u90ce\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u30da\u30a4\u30b7\u30a7\u30f3\u30c8\u30b1\u30a2\uff0e\u8328\u57ce\u770c\u7acb\u533b\u7642\u5927\u5b66\u30012021.7.12<\/li>\n\n\n\n
                          2. \u76f8\u6fa4\u5065\u592a\u90ce\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u30ea\u30b9\u30af\u8ad6\uff0e\u8328\u57ce\u770c\u7acb\u533b\u7642\u5927\u5b66\u30012021.7.19<\/li>\n\n\n\n
                          3. \u7389\u6728\u7fa9\u96c4\uff0e\u653e\u5c04\u7dda\u7642\u6cd5\uff0e\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u770b\u8b77\u5c02\u9580\u5b66\u96622\u5e74\u8ab2\u7a0b\u30012021.6<\/li>\n\n\n\n
                          4. \u7389\u6728\u7fa9\u96c4\uff0e\u5148\u7aef\u653e\u5c04\u7dda\u6cbb\u7642\u5b66\u7279\u8ad6\uff0e\u8328\u57ce\u770c\u7acb\u533b\u7642\u5927\u5b66\u5927\u5b66\u9662\u30012021.7<\/li>\n\n\n\n
                          5. \u7389\u6728\u7fa9\u96c4\uff0e\u9ad8\u5ea6\u653e\u5c04\u7dda\u6cbb\u7642\u6280\u8853\u5b66\u7279\u8ad6\uff0e\u8328\u57ce\u770c\u7acb\u533b\u7642\u5927\u5b66\u5927\u5b66\u9662\u30012022.2<\/li>\n\n\n\n
                          6. \u6d77\u8001\u6839\u8056\u5b50\uff0e\u6210\u4eba\u770b\u8b77\u2161\u653e\u5c04\u7dda\u7642\u6cd5\u770b\u8b77\uff0e\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u770b\u8b77\u5c02\u9580\u5b66\u96623\u5e74\u8ab2\u7a0b\u30012021.11<\/li>\n<\/ol>\n\n\n\n

                            \u4ee4\u548c2\u5e74\u5ea6<\/h3>\n\n\n\n

                            \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                              \n
                            1. Tani K\u3001Wakita A\u3001Tohyama N\u3001Yukio Fujita Y\u3001Kito S\u3001Miyasaka R\u3001Mizuno N\u3001Uehara R\u3001Takakura T\u3001Miyake S\u3001Shinoda K\u3001Oka Y\u3001Saito Y\u3001Kojima H\u3001Hayashi N. Evaluation of differences and dosimetric influences of beam models using golden and multiinstitutional measured beam datasets in radiation treatment planning systems. Medical Physics\u300147 (11):5852-5871\u30012020<\/li>\n<\/ol>\n\n\n\n

                              \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

                                \n
                              1. Yasue K\u3001Fuse H\u3001Shinoda K\u3001Fujisaki T\u3001Tamaki Y\uff0eComparison of the target dose using phase gated and amplitude gated lung stereotactic radiotherapy. \u7b2c 119 \u56de\u65e5\u672c\u533b\u5b66\u7269\u7406\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30012020.5\uff08\u6a2a\u6d5c\u3001\u30a6\u30a7\u30d6\uff09<\/li>\n<\/ol>\n\n\n\n
                                  \n
                                1. \u658e\u85e4\u9ad8\u3001\u7389\u6728\u7fa9\u96c4\u3001 \u6751\u4e0a\u57fa\u5f18\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u6afb\u4e95\u82f1\u5e78. \u5b50\u5bae\u9838\u764c\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306e\u518d\u767a\u5f62\u5f0f\u3068\u4e88\u5f8c\u306e\u9061\u53ca\u7684\u89e3\u6790\uff0e\u5c0f\u7dda\u6e90\u6cbb\u7642\u90e8\u4f1a\u7b2c 22 \u56de\u5b66\u8853\u5927\u4f1a\u30012020.5 \uff08\u8a8c\u4e0a\u958b\u50ac\uff09<\/li>\n\n\n\n
                                2. \u658e\u85e4\u9ad8\u3001\u7389\u6728\u7fa9\u96c4\u3001\u6751\u4e0a\u57fa\u5f18\u3001\u99ac\u5834\u656c\u4e00\u90ce\u3001\u77f3\u7530\u4fca\u6a39\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u6afb\u4e95\u82f1\u5e78. \u5b50\u5bae\u9838\u764c\u6839\u6cbb\u7167\u5c04\u7d42\u4e86\u6642\u306e\u518d\u767a\u4e88\u6e2c\u30b9\u30b3\u30a2\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 33 \u56de\u5b66\u8853\u5927\u4f1a\u30012020.11\uff08\u672d\u5e4c\u3001\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                                3. \u6751\u4e0a\u57fa\u5f18\u3001\u658e\u85e4\u9ad8\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u99ac\u5834\u656c\u4e00\u90ce\u3001\u77f3\u7530\u4fca\u6a39\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u5207\u9664\u4e0d\u80fdIII \u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\uff1adurvalumab \u5c0e\u5165\u524d\u5f8c\u306e\u6bd4\u8f03\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 33 \u56de\u5b66\u8853\u5927\u4f1a\u30012020.11\uff08\u672d\u5e4c\u3001\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                                4. \u77f3\u7530\u4fca\u6a39\u3001\u7389\u6728\u7fa9\u96c4\u3001\u6751\u4e0a\u57fa\u5f18\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u6e05\u6c34\u8aa0\u3001\u751f\u99d2\u82f1\u660e\u3001\u6d77\u8001\u6839\u8056\u5b50\uff0e\u96fb\u5b50\u7dda\u306b\u3088\u308b\u5be1\u5206\u5272\u7167\u5c04\u3092\u884c\u3063\u305f\u5916\u9670\u90e8\u30d1\u30b8\u30a7\u30c3 \u30c8\u75c5\u306e 2 \u4f8b\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 33 \u56de\u5b66\u8853\u5927\u4f1a\u30012020.11\uff08\u672d\u5e4c\u3001\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                                5. \u6d77\u8001\u6839\u8056\u5b50\u3001\u77f3\u7530\u4fca\u6a39\u3001\u6751\u4e0a\u57fa\u5f18\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u6e05\u6c34\u8aa0\u3001\u751f\u99d2\u82f1\u660e\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u5730\u57df\u533b\u7642\u9023\u643a\u306b\u3088\u308a\u5916\u6765\u653e\u5c04\u7dda\u6cbb\u7642\u3092\u5b8c\u9042\u3067\u304d\u305f \u30d1\u30b8\u30a7\u30c3\u30c8\u75c5\u306e 2 \u4f8b\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 33 \u56de\u5b66\u8853\u5927\u4f1a\u30012020.11\uff08\u672d\u5e4c\u3001\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                                6. \u6d77\u8001\u6839\u8056\u5b50\u3001\u658e\u85e4\u9ad8\u3001\u6751\u4e0a\u57fa\u5f18\u3001\u99ac\u5834\u656c\u4e00\u90ce\u3001\u77f3\u7530\u4fca\u6a39\u3001\u5b8d\u5009\u512a\u5b50\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u4e73\u764c\u8853\u5f8c\u7167\u5c04\u306b\u3088\u308b\u76ae\u819a\u6c34\u5206\u91cf\u3068\u5f3e\u529b\u6027\u306e\u5909\u5316\u306b \u3064\u3044\u3066\u691c\u8a0e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 33 \u56de\u5b66\u8853\u5927\u4f1a\u30012020.11\uff08\u672d\u5e4c\u3001\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                                7. Yasue K\u3001Fuse H\u3001Shinoda K\u3001Ikoma H\u3001Fujisaki T\u3001Tamaki Y\uff0eDosimetric effect of the baseline shift in the phase and amplitude gated lung SBRT. 20th Asia-Oceania Congress on Medical Physics. 2020.12\uff08Thailand\u3001Web)<\/li>\n\n\n\n
                                8. \u7be0\u7530\u548c\u54c9\uff0eZoom \u306b\u6163\u308c\u3088\u3046 \u2212\u5f53\u9662\u306e\u73fe\u72b6\u2212\uff0e\u8328\u57ce\u770c\u653e\u5c04\u7dda\u6cbb\u7642\u6280\u8853\u7814\u7a76\u4f1a\u30012021.3(\u30a6\u30a7\u30d6)<\/li>\n<\/ol>\n\n\n\n

                                  \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                                    \n
                                  1. \u7be0\u7530\u548c\u54c9\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u8a08\u753b\u306e\u81ea\u52d5\u5316\u306e\u73fe\u72b6\u3068\u672a\u6765\uff083.\u6cbb\u7642\u8a08\u753b\u306e\u81ea\u52d5\u5316\u306e\u53ef\u80fd\u6027\uff09\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u7b2c 80 \u56de\u653e\u5c04\u7dda\u6cbb\u7642\u90e8\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0e2020.4\uff08\u30a6\u30a8\u30d6\uff09<\/li>\n\n\n\n
                                  2. \u7be0\u7530\u548c\u54c9\uff0eIGRT \u306b\u4f34\u3046\u88ab\u3070\u304f\u7dda\u91cf\u306e\u7ba1\u7406\u30fb\u8a18\u9332 -5. \u88ab\u3070\u304f\u7dda\u91cf\u306e\u7ba1\u7406\u30fb\u8a18\u9332(ExacTrac\u30fbSyncTraX)-\uff0e\u533b\u5b66\u7269\u7406\u58eb\u4f1a\u30bb\u30df\u30ca\u30fc\u30012020.8.\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                                  3. \u7389\u6728\u7fa9\u96c4\uff0eOpening remarks\uff0e\u80ba\u764c\u8a3a\u7642\u3092\u8003\u3048\u308b\u4f1a in \u6c34\u6238 2020.9\uff08\u6c34\u6238\u3001\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                                  4. \u7389\u6728\u7fa9\u96c4\uff0e\u77e5\u3063\u3066\u5b89\u5fc3\u653e\u5c04\u7dda\u6cbb\u7642\uff0e2020 \u5e74\u5ea6 \u798f\u5cf6\u52b4\u707d\u75c5\u9662\u30fb\u5730\u57df\u304c\u3093\u8a3a\u7642\u9023\u643a\u62e0\u70b9\u75c5\u9662\u5e02\u6c11\u516c\u958b\u8b1b\u5ea7\u30012021.1\uff08\u3044\u308f\u304d\u3001\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                                  5. \u7be0\u7530\u548c\u54c9\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u88c5\u7f6e\u5c0e\u5165\u306e\u5b9f\u969b \u2212TrueBeam \u5c0e\u5165\u306e\u5b9f\u969b\u2212\uff0e\u7fa4\u99ac\u304c\u3093\u30d7\u30ed 2020 \u5e74\u5ea6\u7b2c 1 \u56de\u5b66\u7269\u7406\u8b1b\u6f14\u4f1a\u30012021.2\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n\n\n\n
                                  6. \u7be0\u7530\u548c\u54c9\uff0e\u306a\u305c\u30b9\u30af\u30ea\u30d7\u30c8\u5229\u7528\u3092\u52e7\u3081\u308b\u306e\u304b\uff0e\u7b2c\uff11\u56de\u6cbb\u7642\u8a08\u753b\u30b9\u30af\u30ea\u30d7\u30c8\u52c9\u5f37\u4f1a\u3010RayStation \u7de8\u3011\u30012021.3\uff08\u30a6\u30a7\u30d6\uff09<\/li>\n<\/ol>\n\n\n\n

                                    \u4ee4\u548c\u5143\u5e74<\/h3>\n\n\n\n

                                    \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                                      \n
                                    1. Ebara T, Ando K, Eishima J, Suzuki M, Kawakami T, Horikoshi H, Tamaki Y. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma. Jpn J Radiol. 37(6):494-499, 2019<\/li>\n\n\n\n
                                    2. Hosaka S, Fukushima H, Nakao T, Suzuki R, Yamaki Y, Tanaka K, Saito T, Mizumoto M, Sakurai H, Fukushima T, Takada H. Patient transfer to receive proton beam therapy during intensive multimodal therapy is safe and feasible for patients with newly diagnosed high-risk neuroblastoma. J Pediatr Hematol Oncol. 42(1):e18-e24, 2020<\/li>\n\n\n\n
                                    3. Inaba M, Nakao T, Hosaka S, Suzuki R, Fukushima H, Yamaki Y, Saito T, Sakashita S, Noguchi M, Minami M, Masumoto T, Mizumoto M, Sakurai H, Fukushima T, Takada H, Urgent proton beam therapy with interinstitutional transfer for patients with intracranial rhabdomyosarcoma: report of 3 cases. J Pediatr Hematol Oncol. 42(1):e12-e17, 2019<\/li>\n\n\n\n
                                    4. Hiroshima Y, Fukumitsu N, Saito T, Numajiri H, Murofushi KN, Ohnishi K, Nonaka T, Ishikawa H, Okumura T, Sakurai H. Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer. Radiotherapy and Oncology. 136(2019):37-43, 2019<\/li>\n\n\n\n
                                    5. \u658e\u85e4 \u9ad8\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5c71\u7e23\u61b2\u53f8\u3001\u5c0f\u5cf6 \u5bdb\u3001\u67f3\u5ddd \u5fb9\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u524d\u5f8c\u306e\u629c\u6b6f\u3001\u653e\u5c04\u7dda\u9aa8\u9ac4\u708e\u304c\u3053\u308f\u3044\uff0e\u88dc\u7db4\u81e8\u5e8a\u300152(4):441-458, 2019<\/li>\n\n\n\n
                                    6. \u65b0\u7530\u548c\u7bc4\u3001\u52d5\u4f53\u8ffd\u8de1\u30b7\u30b9\u30c6\u30e0 SyncTraX FX4 \u5c0e\u5165\u306e\u30e1\u30ea\u30c3\u30c8\u3001MEDICAL NOW 86 \u53f7 2019<\/li>\n\n\n\n
                                    7. \u7be0\u7530\u548c\u54c9\u3001\u5fd7\u7530\u6643\u4e00\u3001\u7551\u4e2d\u661f\u543e\uff1aIMRT \u30b3\u30df\u30c3\u30b7\u30e7\u30cb\u30f3\u30b0\u306e\u305f\u3081\u306e MLC \u30d1\u30e9\u30e1\u30fc\u30bf\u306e\u591a\u65bd\u8a2d\u9593\u6bd4\u8f03\u3001\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u96d1\u8a8c\u300176(4):404-409, 2020<\/li>\n\n\n\n
                                    8. \u67cf \u6c99\u7e54\u3001\u7389\u6728\u7fa9\u96c4\u3001\u6797 \u5b8f\u3001\u9234\u6728\u8056\u4e00\u3001\u85e4\u679d\u771f\u53f8\u3001\u6d77\u85e4\u6b63\u967d\u3001\u9593\u5bae \u7d14\u3001\u4f50\u4e45\u9593\u7531\u9999\u91cc\uff1a\u591a\u8077\u7a2e\u306b\u3088\u308b\u9aa8\u8ee2\u79fb\u30c1\u30fc\u30e0\u306e\u6d3b\u52d5\u72b6\u6cc1\uff0e\u5168\u81ea\u75c5\u5354\u96d1\u8a8c 58(4):31-34, 2019<\/li>\n<\/ol>\n\n\n\n

                                      \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

                                        \n
                                      1. Hiroshima Y, Nitta K, Saitoh T, Ohno T, Shinoda K, Tamaki Y. Stereotactic body radiotherapy using a new real-time tumor tracking system and fiducial markers.ESTRO 38, 2019.4\uff08Milan, Italy\uff09<\/li>\n\n\n\n
                                      2. \u7be0\u7530\u548c\u54c9\uff0c\u65b0\u7530\u548c\u7bc4\uff0c\u9752\u6728\u8aa0\uff0c\u6cb3\u5cf6\u901a\u4e45\uff0c\u751f\u99d2\u82f1\u660e\uff0c\u6e05\u6c34\u8aa0\uff0c\u76f8\u6fa4\u5065\u592a\u90ce\uff0c\u7b39\u6cbc\u76f4\u4eba\u3001\u8907\u6570\u8133\u8ee2\u79fb\u306e\u540c\u6642\u5b9a\u4f4d\u7167\u5c04\u306b\u5bfe\u5fdc\u3057\u305f\u6cbb\u7642\u8a08\u753b\u88c5\u7f6e\u306e\u30b3\u30df\u30c3\u30b7\u30e7\u30cb\u30f3\u30b0\u3001\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a\u30012019.4\uff08\u6a2a\u6d5c\uff09<\/li>\n\n\n\n
                                      3. \u7389\u6728\u7fa9\u96c4\u3001\u658e\u85e4 \u9ad8\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u571f\u65b9\u771f\u543e\u3001\u4e0a\u524d\u6cca\u529f\u3001\u9ad8\u6a4b\u90a6\u660e\uff0e\u5206\u5316\u578b\u7532\u72b6\u817a\u764c\u306b\u5bfe\u3059\u308b\u5916\u6765\u30a2\u30d6\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u52b9\u679c\uff0e\u7b2c 43 \u56de\u65e5\u672c\u982d\u9838\u90e8\u764c\u5b66\u4f1a\u30012019.6(\u91d1\u6ca2)<\/li>\n\n\n\n
                                      4. \u751f\u99d2\u82f1\u660e\u3001\u7be0\u7530\u548c\u54c9\u3001\u658e\u85e4\u9ad8\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u7389\u6728\u7fa9\u96c4\u3001\u65b0\u7530\u548c\u7bc4\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u6e05\u6c34\u8aa0\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u9752\u6728\u8aa0\uff0e\u591a\u767a\u8133\u5b9a\u4f4d\u6cbb\u7642\u8a08\u753b\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u306b\u304a\u3051\u308b\u5bdd\u53f0\u89d2\u5ea6\u6570\u306e\u691c\u8a0e\uff0e\u7b2c 28 \u56de\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u5b66\u4f1a\u30012019.6\uff08\u65b0\u6f5f\uff09<\/li>\n\n\n\n
                                      5. \u7be0\u7530\u548c\u54c9\u3001\u751f\u99d2\u82f1\u660e\u3001\u658e\u85e4 \u9ad8\u3001\u7389\u6728\u7fa9\u96c4\u3001\u99ac\u5834\u656c\u4e00\u90ce\u3001\u65b0\u7530\u548c\u7bc4\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u6e05\u6c34 \u8aa0\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u9752\u6728 \u8aa0\uff0e\u591a\u767a\u8133\u5b9a\u4f4d\u6cbb\u7642\u8a08\u753b\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u306b\u304a\u3051\u308b 5mm MLC \u3068 2.5mm MLC \u3068\u306e\u6bd4\u8f03\u3001\u7b2c 28 \u56de\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u5b66\u4f1a\u30012019.6\uff08\u65b0\u6f5f\uff09<\/li>\n\n\n\n
                                      6. \u7389\u6728\u7fa9\u96c4\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u658e\u85e4 \u9ad8\u3001\u571f\u65b9\u771f\u543e\u3001\u5800 \u5149\u96c4\u3001\u5927\u8d8a \u9756\u3001\u658e\u85e4\u4ec1\u662d\u3001\u98ef\u5cf6\u9054\u751f\uff0e\u76ae\u819a\u75c5\u5909\u306b\u5bfe\u3057\u3066\u653e\u5c04\u7dda\u6cbb\u7642\u3092\u884c\u3063\u305f\u82bd\u7403\u6027\u5f62\u8cea\u7d30\u80de\u69d8\u6a39\u72b6\u7d30\u80de\u816b\u760d\u306e 2 \u4f8b\uff0e\u7b2c 59 \u56de\u65e5\u672c\u30ea\u30f3\u30d1\u7db2\u5185\u7cfb\u5b66\u4f1a\u7dcf\u4f1a\u30012019.6\uff08\u51fa\u96f2\uff09<\/li>\n\n\n\n
                                      7. \u6e05\u6c34 \u8aa0\u3001\u653e\u5c04\u7dda\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc\u306b\u304a\u3051\u308b\u30ea\u30b9\u30af\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u53d6\u308a\u7d44\u307f\u3001\u7b2c 35 \u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u5e2b\u4f1a\u7dcf\u5408\u5b66\u8853\u5927\u4f1a\u30012019.9\uff08\u5927\u5bae\uff09<\/li>\n\n\n\n
                                      8. \u99ac\u5834\u656c\u4e00\u90ce\u3001\u6751\u4e0a\u57fa\u5f18\u3001\u658e\u85e4 \u9ad8\u3001\u7389\u6728\u7fa9\u96c4\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u77e2\u90e8\u6587\u9855\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u304c\u594f\u529f\u3057\u305f\u30e1\u30eb\u30b1\u30eb\u7d30\u80de\u764c\u306e\uff11\u4f8b\uff0e\u7b2c 18 \u56de\u8328\u57ce\u770c\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u30012019.10\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                      9. \u6751\u4e0a\u57fa\u5f18\u3001\u658e\u85e4 \u9ad8\u3001\u7be0\u7530\u548c\u54c9\u3001\u65b0\u7530\u548c\u7bc4\u3001\u93d1\u6728\u5b5d\u4e4b\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u5c40\u6240\u9032\u884c\u5207\u9664\u4e0d\u80fd\u975e\u5c0f\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u5f8c Durvalumab \u7dad\u6301\u7642\u6cd5\u306e\u521d\u671f\u7d4c\u9a13\uff0e\u7b2c 18 \u56de\u8328\u57ce\u770c\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\uff0e2019.10\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                      10. \u6d77\u8001\u6839\u8056\u5b50\u3001\u9ad8\u6a4b\u5915\u5b50\u3001\u4e0a\u91ce\u6f84\u6075\u3001\u658e\u85e4 \u9ad9\u3001\u7389\u6728\u7fa9\u96c4. \u770b\u770b\u9023\u643a\u306b\u3088\u308a\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306e\u76ae\u819a\u30b1\u30a2\u304c\u7d99\u7d9a\u3067\u304d\u305f\u4e00\u4e8b\u4f8b\uff0e\u7b2c 58 \u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012019.10\uff08\u5fb3\u5cf6\uff09<\/li>\n\n\n\n
                                      11. \u751f\u99d2\u82f1\u660e\u3001\u7be0\u7530\u548c\u54c9\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u6e05\u6c34\u8aa0\u3001\u5317\u5cf6\u9999\u5948\u3001\u65b0\u7530\u548c\u7bc4\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u897f\u90e8\u96c5\u548c\u3001\u9752\u6728 \u8aa0\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u96fb\u5b50\u30dd\u30fc\u30bf\u30eb\u753b\u50cf\u88c5\u7f6e\u3092\u7528\u3044\u305f\u5f37\u5ea6\u5909\u8abf\u653e\u5c04\u7dda\u6cbb\u7642\uff08IMRT\uff09\u691c\u8a3c\u306e\u6709\u7528\u6027\uff0e\u7b2c 58 \u56de\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012019.10\uff08\u5fb3\u5cf6)<\/li>\n\n\n\n
                                      12. \u6e05\u6c34 \u8aa0\u3001\u653e\u5c04\u7dda\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc\u306b\u304a\u3051\u308b\u30ea\u30b9\u30af\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u53d6\u308a\u7d44\u307f\u3001\u7b2c 58 \u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012019.10\uff08\u5fb3\u5cf6\uff09<\/li>\n\n\n\n
                                      13. \u67cf \u5f69\u7e54\u3001\u7389\u6728\u7fa9\u96c4\u3001\u6797\u5b8f\u3001\u9234\u6728\u8056\u4e00\u3001\u6c5f\u6751 \u6b63\u535a\u3001\u5927\u6728 \u5b8f\u4ecb\u3001\u30a2\u30dc\u30c3\u30c8\u307f\u306e\u308a\u3001\u9593\u5bae\u7d14\u3001\u5c0f\u5cf6\u53cb\u6075\u3001\u4f50\u4e45\u9593\u7531\u9999\u91cc\u3001\u5c0f\u6cbc\u6075\u7f8e. \u9aa8\u8ee2\u79fb\u30c1\u30fc\u30e0\u6d3b\u52d5\u306e\u52b9\u679c\uff5e\u4e8b\u4f8b\u304b\u3089\u30c1\u30fc\u30e0\u6d3b\u52d5\u3092\u632f\u308a\u8fd4\u308b\uff5e\u3001\u65e5\u672c\u7de9\u548c\u533b\u7642\u5b66\u4f1a\u5f1f\uff12\u56de\u95a2\u6771\u30fb\u7532\u4fe1\u8d8a\u652f\u90e8\u5b66\u8853\u5927\u4f1a\uff0e2019.11\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
                                      14. \u7389\u6728\u7fa9\u96c4\u3001\u658e\u85e4 \u9ad8\u3001\u99ac\u5834\u656c\u4e00\u90ce\uff0e\u5206\u5316\u578b\u7532\u72b6\u817a\u764c\u306b\u5bfe\u3059\u308b\u5916\u6765\u30a2\u30d6\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u52b9\u679c\u3068\u554f\u984c\u70b9. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a 32 \u56de\u5b66\u8853\u5927\u4f1a\u30012019.11(\u540d\u53e4\u5c4b)<\/li>\n\n\n\n
                                      15. \u99ac\u5834\u656c\u4e00\u90ce\u3001\u658e\u85e4 \u9ad8\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u5207\u9664\u4e0d\u80fd III \u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306e\u9061\u53ca\u7684\u89e3\u6790. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a 32 \u56de\u5b66\u8853\u5927\u4f1a\u30012019.11\uff08\u540d\u53e4\u5c4b\uff09<\/li>\n\n\n\n
                                      16. \u658e\u85e4 \u9ad8\u3001\u5927\u897f\u304b\u3088\u5b50\u3001\u77f3\u5ddd \u4ec1\u3001\u661f\u5408\u58ee\u5927\u3001\u6cbc\u5c3b\u6674\u5b50\u3001\u5ba4\u4f0f\u666f\u5b50\u3001\u6c34\u672c\u6589\u5fd7\u3001\u91ce\u4e2d\u54f2\u751f\u3001\u5965\u6751\u654f\u4e4b\u3001\u6afb\u4e95\u82f1\u5e78 \u9593\u8cea\u6027\u80ba\u75be\u60a3\u4f75\u5b58 I\/II \u671f\u975e\u5c0f\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u967d\u5b50\u7dda\u6cbb\u7642\u3001\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a 32 \u56de\u5b66\u8853\u5927\u4f1a\u30012019.11\uff08\u540d\u53e4\u5c4b\uff09<\/li>\n\n\n\n
                                      17. \u7be0\u7530\u548c\u54c9\u3001\u5fd7\u7530\u6643\u4e00\u3001\u7551\u4e2d\u661f\u543e\uff0eIMRT \u30b3\u30df\u30c3\u30b7\u30e7\u30cb\u30f3\u30b0\u306e\u52b9\u7387\u5316\u30fb\u5b89\u5168\u6027\u5411\u4e0a\u306e\u305f\u3081\u306eMLC \u30d1\u30e9\u30e1\u30fc\u30bf\u306e\u591a\u65bd\u8a2d\u9593\u6bd4\u8f03\u3001\u7b2c 66 \u56de,\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u95a2\u6771\u652f\u90e8\u7814\u7a76\u767a\u8868\u30012019.11\uff08\u5343\u8449\uff09<\/li>\n\n\n\n
                                      18. \u658e\u85e4 \u9ad8\u3001\u5927\u897f\u304b\u3088\u5b50\u3001\u77f3\u5ddd\u4ec1\u3001\u4e2d\u6fa4\u5065\u4ecb\u3001\u5869\u6fa4\u5229\u535a\u3001\u91ce\u4e2d\u54f2\u751f\u3001\u5965\u6751\u654f\u4e4b, \u95a2\u6839\u90c1\u592b,\u4f50\u85e4\u5e78\u592b, \u6a9c\u6fa4\u4f38\u4e4b,\u6afb\u4e95\u82f1\u5e78. \u9593\u8cea\u6027\u80ba\u75be\u60a3\u4f75\u5b58\u2160\/\u2161\u671f\u975e\u5c0f\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u967d\u5b50\u7dda\u6cbb\u7642.\u7b2c 60 \u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30012019.12\uff08\u5927\u962a\uff09<\/li>\n\n\n\n
                                      19. \u5b8d\u5009\u512a\u5b50\u3001\u963f\u90e8\u76f4\u7f8e\u3001\u77f3\u5ddd\u6075\u7f8e\u5b50\u3001\u67cf\u5f69\u7e54\u3001\u89d2\u7530\u76f4\u679d\u3001\u65b0\u7530\u548c\u7bc4\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u99ac\u5834\u656c\u4e00\u90ce\u3001\u6589\u85e4\u9ad8\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u773c\u77bc\u30e1\u30eb\u30b1\u30eb\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u7642\u6cd5\u306b\u304a\u3051\u308b\u770b\u8b77\u2015\u5e0c\u5c11\u304c\u3093\u306b\u5bfe\u3059\u308b\u30c1\u30fc\u30e0\u533b\u7642\u2015\uff0e\u7b2c 29 \u56de\u8328\u57ce\u304c\u3093\u5b66\u4f1a\u30012019.12\uff08\u571f\u6d66\uff09<\/li>\n\n\n\n
                                      20. \u5712\u539f\u4e00\u6075\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u4e0a\u91ce\u6f84\u6075\u3001\u9ad8\u6a4b\u77e5\u5b50\u3001\u83ca\u5730\u4e07\u91cc\u6075\u3001\u7a42\u7a4d\u5eb7\u592b\u3001\u5317\u539f\u7f8e\u7531\u7d00\u3001\u7af9\u5185\u76f4\u4eba\u3001\u658e\u85e4 \u9ad8\u3001\u677e\u6728 \u85ab\uff0e\u5de8\u5927\u81ea\u58ca\u5275\u3092\u4f34\u3046\uff344 \u4e73\u304c\u3093\u60a3\u8005\u306e ACP \u5b9f\u8df5\u306e\u4e00\u4e8b\u4f8b\uff0e16 \u56de\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30012019.12\uff08\u5927\u5bae\uff09<\/li>\n<\/ol>\n\n\n\n

                                        \u3010\u8b1b\u6f14\u3011<\/p>\n\n\n\n

                                          \n
                                        1. \u7be0\u7530\u548c\u54c9\uff0e\u8907\u6570\u8133\u8ee2\u79fb\u306e\u540c\u6642\u7167\u5c04\u306b\u5bfe\u5fdc\u3057\u305f\u6cbb\u7642\u8a08\u753b\u88c5\u7f6e\u306e\u30b3\u30df\u30c3\u30b7\u30e7\u30cb\u30f3\u30b0\uff0e\u304c\u3093\u30bb\u30f3\u30bf\u30fc\u591a\u5730\u70b9\u5408\u540c\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30012019.5\uff08\u7b20\u9593\uff09<\/li>\n\n\n\n
                                        2. \u7be0\u7530\u548c\u54c9\uff0e\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u306e\u672a\u6765\u301c\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u3092\u984c\u6750\u3068\u3057\u305f\u6f2b\u753b\uff06\u30c9\u30e9\u30de\u3068\u306e\u95a2\u308f\u308a\u304b\u3089\u4f1d\u3048\u305f\u3044\u3053\u3068\u301c\uff0e\u8328\u57ce\u770c\u7acb\u533b\u7642\u5927\u5b66\u30aa\u30fc\u30d7\u30f3\u30ad\u30e3\u30f3\u30d1\u30b9\u30012019.7\uff08\u963f\u898b\uff09<\/li>\n\n\n\n
                                        3. \u7be0\u7530\u548c\u54c9\uff0e5mm MLC \u306b\u3088\u308b Elements Multiple Brain Mets SRS \u306e \u521d\u671f\u4f7f\u7528\u7d4c\u9a13\uff0e\u30d6\u30ec\u30a4\u30f3\u30e9\u30dc\u30bb\u30df\u30ca\u30fc\u30012019.7\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
                                        4. \u7be0\u7530\u548c\u54c9\uff0eDIBH \u306e\u81e8\u5e8a\u5c0e\u5165\u301cabches \u30d0\u30fc\u30b7\u30e7\u30f3\u301c\uff0e\u7b2c 7 \u56de\u3064\u304f\u3070 RT \u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30012019.10\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
                                        5. \u7be0\u7530\u548c\u54c9\uff0e\u8328\u57ce STI \u8a08\u753b\u30c8\u30e9\u30a4\u30a2\u30eb 2019\uff1b\u770c\u5185\u65bd\u8a2d\u306e\u6cbb\u7642\u8a08\u753b\u306e\u73fe\u72b6\u306e\u6982\u8aac\uff0e2019.12\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
                                        6. \u6d77\u8001\u6839\u8056\u5b50\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u4e2d\u306e\u76ae\u819a\u30b1\u30a2\u306b\u3064\u3044\u3066\u3001\u7b2c 6 \u56de\u8328\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u770b\u8b77\u30bb\u30df\u30ca\u30fc.2019.11(\u7b20\u9593\uff09<\/li>\n<\/ol>\n\n\n\n

                                          \u5e73\u621030\u5e74\u5ea6<\/h3>\n\n\n\n

                                          \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                                            \n
                                          1. Inada K, Okoshi Y, Cho-Isoda Y, Ishiguro S, Suzuki H, Oki A, Tamaki Y, Shimazui T, Saito H, Hori M, Iijima T, Kojima H. Endogenous reference RNAs for microRNA quantitation in formalin fixed, paraffin-embedded lymph node tissue. Sci Rep.8(1):5918, 2018.<\/li>\n<\/ol>\n\n\n\n

                                            \u3010\u5b66\u4f1a\u767a\u8868\u3011
                                            \u533b\u5e2b\uff1a<\/p>\n\n\n\n

                                              \n
                                            1. \u5ee3\u5d8b\u60a0\u4e00\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u6e05\u6c34 \u8aa0\u3001\u751f\u99d2\u82f1\u660e\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u9752\u6728 \u8aa0\u3001\u77f3\u7530\u4fca\u6a39\u3001\u658e\u85e4 \u9ad8\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u52d5\u4f53\u8ffd\u8de1\u30b7\u30b9\u30c6\u30e0\u3092\u7528\u3044\u305f\u4f53\u5e79\u90e8\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u521d\u671f\u7d4c\u9a13\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 31 \u56de\u5b66\u8853\u5927\u4f1a\u30012018.10\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                            2. \u6c38\u5cf6 \u6f64\u3001\u5b89\u85e4 \u8b19\u3001\u6c5f\u539f \u5a01\u3001\u6e05\u6c34\u7fa9\u660e\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u4e2d\u7a0b\u5ea6\u5be1\u5206\u5272\u5f37\u5ea6\u653e\u5c04\u7dda\u6cbb\u7642(64.4Gy\/23 \u56de,\u9031 3 \u56de\u6cd5)\u306e 5 \u5e74\u9593\u306e\u6210\u7e3e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 31 \u56de\u5b66\u8853\u5927\u4f1a\u30012018.10.11\uff08\u4eac\u90fd\uff09(\u53e3\u6f14)<\/li>\n\n\n\n
                                            3. \u77f3\u7530\u4fca\u6a39\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u658e\u85e4 \u9ad8\u3001\u5ee3\u5d8b\u60a0\u4e00\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u304c\u594f\u529f\u3057\u305f\u5b64\u7acb\u6027\u7dda\u7dad\u6027\u816b\u760d\u306e 1 \u4f8b\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 31 \u56de\u5b66\u8853\u5927\u4f1a\u30012018.10\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                            4. Hiroshima Y, Tamaki Y, Saitoh T, Ohno T, Shinoda K, Nitta K. Stereotactic body radiotherapy using a real time tumor tracking system. ESTRO meets ASIA 2018, 2018.12\uff08\u30b7\u30f3\u30ac\u30dd\u30fc\u30eb)<\/li>\n\n\n\n
                                            5. \u571f\u65b9\u771f\u543e\u3001\u6589\u85e4\u9ad8\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u80ba\u764c\u306e\u9aa8\u8ee2\u79fb\u306b\u5bfe\u3059\u308b 89Sr \u306e\u6709\u52b9\u6027\u3068 SUV peak \u3092\u7528\u3044\u305f\u52b9\u679c\u4e88\u6e2c\uff0e\u7b2c 16 \u56de\u8328\u57ce\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u30012018.11\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                            6. \u658e\u85e4\u9ad8\u3001\u7be0\u7530\u548c\u54c9\u3001\u571f\u65b9\u771f\u543e\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u65b0\u7530\u548c\u7bc4\u3001\u751f\u99d2\u82f1\u660e\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306e\u5358\u767a\u307e\u305f\u306f\u5c11\u6570\u500b\u306e\u8ee2\u79fb\u6027\u8133\u816b\u760d\u306b\u5bfe\u3059\u308b\u30ea\u30cb\u30a2\u30c3\u30af\u30d9\u30fc\u30b9\u5b9a\u4f4d\u624b\u8853\u7684\u7167\u5c04\u306e\u9061\u53ca\u7684\u89e3\u6790\uff0e\u7b2c 32 \u56de\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u5916\u90e8\u7167\u5c04\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\u30012019.3\uff08\u6771\u4eac\uff09<\/li>\n<\/ol>\n\n\n\n

                                              \u7269\u7406\u58eb\u30fb\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\uff1a<\/p>\n\n\n\n

                                                \n
                                              1. \u751f\u99d2\u82f1\u660e\uff0e\u9707\u707d\u304b\u3089\u306e\u5fa9\u65e7\u306b\u5411\u3051\u3066\u8003\u3048\u308b\uff0d\u7ba1\u7406\u533a\u57df\u306e\u5b89\u5168\u3068\u7dda\u91cf\u7ba1\u7406\uff0d\u3001\u653e\u5c04\u7dda\u6cbb\u7642\u88c5\u7f6e\u306e\u5b89\u5168\u70b9\u691c\u3068\u6f0f\u6d29\u7dda\u91cf\u306e\u6e2c\u5b9a\uff0c\u7dda\u91cf\u7ba1\u7406\u3001\u7b2c 46 \u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a\u30fb\u7b2c 52 \u56de\u8a08\u6e2c\u90e8\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u30012018.10.\uff08\u4ed9\u53f0\uff09<\/li>\n\n\n\n
                                              2. \u65b0\u7530\u548c\u7bc4\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u751f\u99d2\u82f1\u660e\u3001\u7be0\u7530\u548c\u54c9\u3001\u6e05\u6c34 \u8aa0\u3001\u658e\u85e4 \u9ad8\u3001\u7389\u6728\u7fa9\u96c4\uff1a\u547c\u5438\u505c\u6b62\u4e0b\u306b\u3088\u308b X \u7dda\u52d5\u4f53\u8ffd\u8de1\u30b7\u30b9\u30c6\u30e0\u3092\u7528\u3044\u305f PTV \u30de\u30fc\u30b8\u30f3\u7e2e\u5c0f\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff0e\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 31 \u56de\u5b66\u8853\u5927\u4f1a\u30012018.10.\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                              3. \u7be0\u7530\u548c\u54c9\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7389\u6728\u7fa9\u96c4\u3001\u6589\u85e4 \u9ad8\u3001\u5ee3\u5d8b\u60a0\u4e00\uff0eMultiple Brain Mets SRS \u306e\u4f7f\u7528\u7d4c\u9a13\uff0e\u7b2c 12 \u56de\u8328\u57ce\u770c\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u4f1a \u653e\u5c04\u7dda\u6cbb\u7642\u6280\u8853\u7814\u7a76\u4f1a\u30012019.1\uff08\u7b20\u9593\uff09<\/li>\n\n\n\n
                                              4. \u751f\u99d2\u82f1\u660e\u3001\u7be0\u7530\u548c\u54c9\u3001\u5317\u5cf6\u9999\u5948\u3001\u6e05\u6c34 \u8aa0\u3001\u65b0\u7530\u548c\u7bc4\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u897f\u90e8\u96c5\u548c\u3001\u9752\u6728\u8aa0\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u5f37\u5ea6\u5909\u8abf\u653e\u5c04\u7dda\u6cbb\u7642\uff08IMRT\uff09\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u691c\u8a3c\u6cd5\u306e\u6709\u7528\u6027\uff0e\u7b2c 28 \u56de\u8328\u57ce\u304c\u3093\u5b66\u4f1a\u30012019.1\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                              5. \u6e05\u6c34 \u8aa0\u3001\u5317\u5cf6\u9999\u5948\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u751f\u99d2\u82f1\u660e\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u897f\u90e8\u96c5\u548c\u3001\u9752\u6728 \u8aa0\u3001\u7be0\u7530\u548c\u54c9\u3001\u65b0\u7530\u548c\u7bc4\u3001\u4e0a\u91ce\u771f\u6a39\u3001\u77f3\u5ddd\u6075\u7f8e\u5b50\u3001\u6c38\u5800\u7f8e\u5e78\u3001\u5b8d\u5009\u512a\u5b50\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u571f\u65b9\u771f\u543e\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u6589\u85e4 \u9ad8\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc\u306b\u304a\u3051\u308b\u30ea\u30b9\u30af\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u53d6\u308a\u7d44\uff0e\u7b2c 28 \u56de\u8328\u57ce\u304c\u3093\u5b66\u4f1a\u30012019.1\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                              6. \u6e05\u6c34 \u8aa0\u3001\u5317\u5cf6\u9999\u5948\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u751f\u99d2\u82f1\u660e\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u897f\u90e8\u96c5\u548c\u3001\uff0c\u9752\u6728 \u8aa0\u3001\u7be0\u7530\u548c\u54c9\u3001\u65b0\u7530\u548c\u7bc4\u3001\u4e0a\u91ce\u771f\u6a39\u3001\u77f3\u5ddd\u6075\u7f8e\u5b50\u3001\u6c38\u5800\u7f8e\u5e78\u3001\u5b8d\u5009\u512a\u5b50\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u571f\u65b9\u771f\u543e\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u6589\u85e4 \u9ad8\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc\u306b\u304a\u3051\u308b\u30ea\u30b9\u30af\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u306e\u53d6\u308a\u7d44\u307f\uff0e\u7b2c 17 \u56de\u8328\u57ce\u770c\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u30012019.3\uff08\u6c34\u6238\uff09<\/li>\n<\/ol>\n\n\n\n

                                                \u770b\u8b77\u5e2b\uff1a<\/p>\n\n\n\n

                                                  \n
                                                1. \u67cf \u6c99\u7e54\u3001\u7389\u6728\u7fa9\u96c4\u3001\u658e\u85e4 \u9ad8\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u6797 \u5b8f\u3001\u5150\u5c71 \u5065\u3001\u85e4\u679d\u771f\u53f8\uff0e\u5f53\u9662\u306b\u304a\u3051\u308b\u9aa8\u8ee2\u79fb\u30c1\u30fc\u30e0\u306e\u6d3b\u52d5\u72b6\u6cc1\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 31 \u56de\u5b66\u8853\u5927\u4f1a\u30012018.10\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                                2. \u67cf\u6c99\u7e54\u3001\u7389\u6728\u7fa9\u96c4\u3001\u6797 \u5b8f\u3001\u9234\u6728\u8056\u4e00\u3001\u85e4\u679d\u771f\u53f8\u3001\u6d77\u9053\u6b63\u967d\u3001\u9593\u5bae\u7d14\u3001\u4f50\u4e45\u9593\u7531\u9999\u91cc\uff0e\u591a\u8077\u7a2e\u306b\u3088\u308b\u9aa8\u8ee2\u79fb\u30c1\u30fc\u30e0\u306e\u6d3b\u52d5\u72b6\u6cc1\uff0e\u7b2c 57 \u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012018.10\uff08\u90e1\u5c71\uff09<\/li>\n<\/ol>\n\n\n\n

                                                  \u3010\u8b1b\u6f14\u3011
                                                  \u533b\u5e2b\uff1a<\/p>\n\n\n\n

                                                    \n
                                                  1. \u658e\u85e4 \u9ad8\uff0eIII \u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u306e\u5f53\u9662\u3067\u306e\u7d4c\u9a13\u3068\u8ab2\u984c\uff0eLung cancer Symposium in Mito\u30012018.10\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                  2. \u5ee3\u5d8b\u60a0\u4e00\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u658e\u85e4 \u9ad8\u3001\u571f\u65b9\u771f\u543e\u3001\u7389\u6728\u7fa9\u96c4\uff0eSyncTraX FX4 \u3092\u7528\u3044\u305f\u5b9a\u4f4d\u4f53\u5e79\u90e8\u653e\u5c04\u7dda\u6cbb\u7642\u3092\u884c\u3063\u305f\u521d\u671f\u7d4c\u9a13 -\u81e8\u5e8a\u7684\u5074\u9762\u304b\u3089-\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a \u7b2c31 \u56de\u5b66\u8853\u5927\u4f1a\uff08\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff092019.10\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                                  3. \u7389\u6728\u7fa9\u96c4\uff0eRI \u5185\u7528\u7642\u6cd5\u306e\u73fe\u72b6\u3068\u5c06\u6765\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u6280\u8853\u7814\u7a76\u4f1a\u30012019.1\uff08\u7b20\u9593\uff09<\/li>\n<\/ol>\n\n\n\n

                                                    \u7269\u7406\u58eb\u30fb\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\uff1a<\/p>\n\n\n\n

                                                      \n
                                                    1. \u7be0\u7530\u548c\u54c9\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u54c1\u8cea\u7ba1\u7406\u4f53\u5236\u306e\u69cb\u7bc9\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u6cbb\u7642\u5c02\u9580\u653e\u5c04\u7dda\u6280\u5e2b\u8a8d\u5b9a\u6a5f\u69cb\u8b1b\u7fd2\u4f1a\uff08\u95a2\u6771\u2160\u30d6\u30ed\u30c3\u30af\uff09\u30012018.9\uff08\u9577\u91ce\uff09<\/li>\n\n\n\n
                                                    2. \u65b0\u7530\u548c\u7bc4\uff0e\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308b SyncTraX FX4 \u306e\u521d\u671f\u7d4c\u9a13\u3001\u6771\u4eac\u653e\u5c04\u7dda\u6cbb\u7642\u8ac7\u8a71\u4f1a\u30012018.10\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
                                                    3. \u65b0\u7530\u548c\u7bc4\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u7be0\u7530\u548c\u54c9\u3001\u658e\u85e4 \u9ad8\u3001\u571f\u65b9\u771f\u543e\u3001\u7389\u6728\u7fa9\u96c4\uff0eSyncTraX FX4 \u3092\u7528\u3044\u305f\u5b9a\u4f4d\u4f53\u5e79\u90e8\u653e\u5c04\u7dda\u6cbb\u7642\u3092\u884c\u3063\u305f\u521d\u671f\u7d4c\u9a13-\u6280\u8853\u7684\u5074\u9762\u304b\u3089-\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a \u7b2c31 \u56de\u5b66\u8853\u5927\u4f1a\uff08\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff09\u30012019.10\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                                    4. \u7be0\u7530\u548c\u54c9\uff0eVMAT \u306e\u81e8\u5e8a\uff0e\u5e73\u6210 30 \u5e74\u5ea6\u7b2c 5 \u56de\u95a2\u6771 RT \u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc\u30012018.12\uff08\u5b87\u90fd\u5bae\uff09<\/li>\n\n\n\n
                                                    5. \u7be0\u7530\u548c\u54c9\u3001\u751f\u99d2\u82f1\u660e\uff0eVarian TrueBeam \u5f53\u9662\u3067\u306e\u7acb\u3061\u4e0a\u3052\u3068\u4f7f\u7528\u7d4c\u9a13\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u3001\u95a2\u6771\u30fb\u6771\u4eac\u652f\u90e8\u5408\u540c\u7814\u7a76\u767a\u8868\u5927\u4f1a 2018\uff08\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff09\u30012018.12\uff08\u3055\u3044\u305f\u307e\uff09<\/li>\n\n\n\n
                                                    6. \u751f\u99d2\u82f1\u660e\uff0e\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308b Simple QA \u3068 MU \u306e\u5229\u7528\u7d4c\u9a13\uff0e\u7b2c 6 \u56de\u5148\u7aef\u6280\u8853\u7814\u7a76\u4f1a\uff08\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff09\u30012018.12\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
                                                    7. \u7be0\u7530\u548c\u54c9\uff0eRayStation \u306e\u512a\u4f4d\u6027\u3068\u4eca\u5f8c\u306e\u6d3b\u7528\u306b\u5411\u3051\u3066\uff0e\u7b2c 5 \u56de RayStation \u30e6\u30fc\u30b6\u30fc\u30bb\u30df\u30ca\u30fc\u30012019.2\uff08\u6771\u4eac\uff09<\/li>\n<\/ol>\n\n\n\n

                                                      \u5e73\u621029\u5e74\u5ea6<\/p>\n\n\n\n

                                                      \u3010\u8457\u66f8\u3001\u4ed6\u3011<\/p>\n\n\n\n

                                                        \n
                                                      1. \u751f\u99d2\u82f1\u660e\uff1a\u8328\u57ce\uff08\u3044\u3070\u3089\u304d\uff09\u306e\u201d\u4eca\u201d\u3068\u3053\u308c\u304b\u3089\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a JASTRO NEWSLETTER\uff08\u653e\u5c04\u7dda\u6280\u5e2b\u30fb\u533b\u5b66\u7269\u7406\u58eb\u306e\u30b3\u30fc\u30ca\u30fc\uff09124 \u53f7,2017<\/li>\n<\/ol>\n\n\n\n

                                                        \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

                                                          \n
                                                        1. Ebara T, Ando K, Kawahara M, Suzuki M, Horikoshi H, Tamaki Y: Radiation and concurrent super-selective intra-arterial cisplatinfor maxillary sinus cancer. 36th Conference of European Society for Radiotherapy and Oncology (ESTRO36), 2017.5 (Vienna, Austria)<\/li>\n\n\n\n
                                                        2. \u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u5bae\u5185\u5927\u609f\u3001\u5965\u6751\u654f\u4e4b\u3001\u6afb\u4e95\u82f1\u5e78\uff0e\u83cc\u72b6\u606f\u8089\u816b\u75c7\u306b\u5bfe\u3059\u308b\u5168\u8eab\u76ae\u819a\u96fb\u5b50\u7dda\u6cbb\u7642\uff0e\u7b2c 57 \u56de\u30ea\u30f3\u30d1\u7db2\u5185\u7cfb\u5b66\u4f1a\u7dcf\u4f1a\u30012017.7 \uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
                                                        3. \u6e05\u6c34\u7fd4\u661f\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u5bae\u5185\u5927\u609f\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u7389\u6728\u7fa9\u96c4\uff0eRa-223 \u306e\u521d\u671f\u7d4c\u9a13\uff0e\u7b2c 14 \u56de\u8328\u57ce\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u30012017.9 \uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                        4. \u5317\u5cf6\u9999\u5948\u3001\u6e05\u6c34 \u8aa0\u3001\u751f\u99d2\u82f1\u660e\u3001\u7be0\u7530\u548c\u54c9\u3001\u65b0\u7530\u548c\u7bc4\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u897f\u90e8\u96c5\u548c\u3001\u9752\u6728 \u8aa0\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u6e05\u6c34\u7fd4\u661f\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u7389\u6728\u7fa9\u96c4\uff0eTrueBeam STX \u306b\u304a\u3051\u308b\u65e5\u5e38\u70b9\u691c\u306b\u3064\u3044\u3066\u3001\u7b2c 14 \u56de\u8328\u57ce\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u30012017.9\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                        5. \u751f\u99d2\u82f1\u660e\u3001\u7be0\u7530\u548c\u54c9\u3001\u65b0\u7530\u548c\u7bc4\u3001\u6e05\u6c34 \u8aa0\u3001\u5317\u5cf6\u9999\u5948\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u897f\u90e8\u96c5\u548c\u3001\u9752\u6728 \u8aa0\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u6e05\u6c34\u7fd4\u661f\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u65b0\u30ea\u30cb\u30a2\u30c3\u30af\u306b\u304a\u3051\u308b\u5404\u30a8\u30cd\u30eb\u30ae\u30fc\u306e\u57fa\u672c\u7279\u6027\u3001\u7b2c 14 \u56de\u8328\u57ce\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u30012017.9\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                        6. \u65b0\u7530\u548c\u7bc4\u3001\u751f\u99d2\u82f1\u660e\u3001\u7be0\u7530\u548c\u54c9\u3001\u6e05\u6c34\u8aa0\u3001\u5317\u5cf6\u9999\u5948\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u65b0\u578b\u653e\u5c04\u7dda\u6cbb\u7642\u52d5\u4f53\u8ffd\u8de1\u30b7\u30b9\u30c6\u30e0 SyncTraXFX4 \u306b\u304a\u3051\u308b\u52d5\u4f53\u8ffd\u8de1\u7cbe\u5ea6\u306e\u57fa\u790e\u7684\u8a55\u4fa1\u3001\u7b2c 56 \u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012017.10\uff08\u5343\u8449\uff09<\/li>\n\n\n\n
                                                        7. \u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u5bae\u5185\u5927\u609f\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u6d77\u8001\u6839\u8056\u5b50\uff0e\u7532\u72b6\u817a\u764c\u306b\u5bfe\u3059\u308b\u5916\u6765\u30a2\u30d6\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u521d\u671f\u7d4c\u9a13\u3001\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 30 \u56de\u5b66\u8853\u5927\u4f1a\u30012017.11\uff08\u5927\u962a\uff09<\/li>\n\n\n\n
                                                        8. \u5bae\u5185\u5927\u609f\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u6e05\u6c34 \u8aa0\u3001\u751f\u99d2\u82f1\u660e\u3001\u9752\u6728 \u8aa0\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u5c0e\u5165\u5316\u5b66\u7642\u6cd5\u3092\u884c\u3063\u305f\u508d\u5927\u52d5\u8108\u30ea\u30f3\u30d1\u7bc0\u8ee2\u79fb\u3092\u6709\u3059\u308b\u5b50\u5bae\u9838\u764c\u306e\u6cbb\u7642\u6210\u7e3e\u3001\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 30 \u56de\u5b66\u8853\u5927\u4f1a\u30012017.11\uff08\u5927\u962a\uff09<\/li>\n\n\n\n
                                                        9. \u5ee3\u5d8b\u60a0\u4e00\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u5bae\u5185\u5927\u609f\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u6e05\u6c34 \u8aa0\u3001\u751f\u99d2\u82f1\u660e\u3001\u9752\u6728 \u8aa0\u3001\u6d77\u8001\u6839\u8056\u5b50\uff0eIMRT \u3092\u65bd\u884c\u3057\u305f\u9650\u5c40\u6027\u524d\u7acb\u817a\u764c\u306b\u304a\u3051\u308b IPSS \u306e\u5897\u60aa\u56e0\u5b50\u306b\u95a2\u3059\u308b\u691c\u8a0e\u3001\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 30 \u56de\u5b66\u8853\u5927\u4f1a\u30012017.11\uff08\u5927\u962a\uff09<\/li>\n\n\n\n
                                                        10. \u7be0\u7530\u548c\u54c9\u3001\u751f\u99d2\u82f1\u660e\u3001\u65b0\u7530\u548c\u7bc4\u3001\u4ed6\uff0eEvaluation of the 0.07cc type ionization chamber from TrueBeam STx commissioning data\u3001\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30012017.11\uff08\u5927\u962a\uff09<\/li>\n\n\n\n
                                                        11. \u6c5f\u539f \u5a01\u3001\u5b89\u85e4 \u8b19\u3001\u6c38\u5cf6 \u6f64\u3001\u9234\u6728\u653f\u7f8e\u3001\u5800\u8d8a\u6d69\u5e78\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u4e0a\u984e\u6d1e\u764c\u306b\u5bfe\u3059\u308b\u8d85\u9078\u629e\u7684\u52d5\u6ce8\u4f75\u7528\u653e\u5c04\u7dda\u6cbb\u7642\u3001\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 30 \u56de\u5b66\u8853\u5927\u4f1a\u30012017.11\uff08\u5927\u962a\uff09<\/li>\n\n\n\n
                                                        12. \u6c38\u5cf6 \u6f64\u3001\u5b89\u85e4 \u8b19\u3001\u6c5f\u539f \u5a01\u3001\u6751\u5c71\u4f73\u4e88\u5b50\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u80c3\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u3001\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 30 \u56de\u5b66\u8853\u5927\u4f1a\u30012017.11\uff08\u5927\u962a\uff09<\/li>\n\n\n\n
                                                        13. \u5ee3\u5d8b\u60a0\u4e00\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u6e05\u6c34\u7fd4\u661f\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u6e05\u6c34 \u8aa0\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u5317\u5cf6\u9999\u5948\u3001\u751f\u99d2\u82f1\u660e\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u52d5\u4f53\u8ffd\u8de1\u30b7\u30b9\u30c6\u30e0 SyncTraX FX4 \u3068\u91d1\u30de\u30fc\u30ab\u30fc\u3092\u7528\u3044\u305f\u80ba\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u521d\u671f\u7d4c\u9a13\u3001\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 31 \u56de\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u6cbb\u7642\u90e8\u4f1a\u5b66\u8853\u5927\u4f1a\u30012018.2(\u5927\u962a)<\/li>\n\n\n\n
                                                        14. \u77f3\u7530\u4fca\u6a39\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u5ee3\u5d8b\u60a0\u4e00\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u304c\u594f\u529f\u3057\u305f Solitary fibrous tumor \u306e 1 \u4f8b\u3001\u7b2c 15 \u56de\u8328\u57ce\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u30012018.2\uff08\u3064\u304f\u3070\uff09\uff1b\u512a\u79c0\u6f14\u984c\u8cde<\/li>\n\n\n\n
                                                        15. \u65b0\u7530\u548c\u7bc4\uff0cVMAT \u306e\u81e8\u5e8a\u5fdc\u7528\u306b\u95a2\u3059\u308b\u5404\u65bd\u8a2d\u767a\u8868-\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662-\u3001\u7b2c 11 \u56de\u8328\u57ce\u770c\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u4f1a\u653e\u5c04\u7dda\u6cbb\u7642\u6280\u8853\u7814\u7a76\u4f1a\u30012018.2\uff08\u7b20\u9593\uff09<\/li>\n\n\n\n
                                                        16. \u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5ee3\u5d8b\u60a0\u4e00\u3001\u77f3\u7530\u4fca\u6a39\u3001\u897f\u90e8\u96c5\u548c\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u751f\u99d2\u82f1\u660e\u3001\u6e05\u6c34 \u8aa0\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u7b39\u6cbc\u76f4\u4eba\u3001\u5317\u5cf6\u9999\u5948\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7be0\u7530\u548c\u54c9\u3001\u67cf \u6c99\u7e54\u3001\u5b8d\u5009\u512a\u5b50\u3001\u6c38\u5800\u7f8e\u5e78\u3001\u77f3\u5ddd\u6075\u7f8e\u5b50\u3001\u6d77\u8001\u6839\u8056\u5b50\uff0eIMRT \u3092\u7528\u3044\u305f\u5b50\u5bae\u9838\u764c\u306b\u5bfe\u3059\u308b\u8853\u5f8c\u7167\u5c04\u306e\u6cbb\u7642\u6210\u7e3e\u3001\u7b2c15 \u56de\u8328\u57ce\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u30012018.2\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
                                                        17. \u5ee3\u5d8b\u60a0\u4e00\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u9234\u6728\u4e45\u53f2\u3001\u6e05\u5cf6\u8b77\u4e4b\u3001\u93d1\u6728\u5b5d\u4e4b\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u52d5\u4f53\u8ffd\u8de1\u30b7\u30b9\u30c6\u30e0SyncTrax FX4 \u3068\u91d1\u30de\u30fc\u30ab\u30fc\u3092\u7528\u3044\u305f\u80ba\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u521d\u671f\u7d4c\u9a13\uff0e\u7b2c 44 \u56de\u8328\u57ce\u80ba\u764c\u7814\u7a76\u4f1a\u30012018.3\uff08\u7b20\u9593\uff09<\/li>\n<\/ol>\n\n\n\n

                                                          \u3010\u8b1b\u6f14\u3001\u8b1b\u7fa9\u3011<\/p>\n\n\n\n

                                                            \n
                                                          1. \u7389\u6728\u7fa9\u96c4\uff0e\u80ba\u764c\u306e\u653e\u5c04\u7dda\u6cbb\u7642\uff0e\u8328\u57ce\u770c\u80ba\u304c\u3093\u5e02\u6c11\u516c\u958b\u30bb\u30df\u30ca\u30fc in \u6c34\u6238\u4ee5\u5317\u30012017.5\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                          2. \u7389\u6728\u7fa9\u96c4\uff0e\u653e\u5c04\u7dda\u3068\u653e\u5c04\u80fd\u306e\u57fa\u790e\u77e5\u8b58\uff0e\u5e73\u6210 29 \u5e74\u5ea6\u539f\u5b50\u529b\u9632\u707d\u57fa\u790e\u7814\u4fee\u30012017.7\uff08\u3072\u305f\u3061\u306a\u304b\uff09<\/li>\n\n\n\n
                                                          3. \u7389\u6728\u7fa9\u96c4\uff0e\u653e\u5c04\u7dda\u3068\u653e\u5c04\u80fd\u306e\u57fa\u790e\u77e5\u8b58\uff0e\u5e73\u6210 29 \u5e74\u5ea6\u539f\u5b50\u529b\u9632\u707d\u57fa\u790e\u7814\u4fee 2017.7\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                          4. \u7389\u6728\u7fa9\u96c4\uff0e\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308b\u653e\u5c04\u7dda\u6cbb\u7642 -\u73fe\u72b6\u3068\u4eca\u5f8c\u306e\u5c55\u958b\uff0e\u5e73\u6210 29 \u5e74\u5ea6\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u5730\u57df\u9023\u643a\u533b\u7642\u63a8\u9032\u61c7\u8ac7\u4f1a\u30012017.11\uff08\u7b20\u9593\uff09<\/li>\n\n\n\n
                                                          5. \u751f\u99d2\u82f1\u660e\uff0e\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308b\u52d5\u4f53\u8ffd\u8de1\u30b7\u30b9\u30c6\u30e0 SyncTraXFX4 \u306e\u4f7f\u7528\u7d4c\u9a13\uff0e\u7b2c5\u56de\u5148\u7aef\u6280\u8853\u7814\u7a76\u4f1a\u30012017.12\uff08\u67cf\uff09<\/li>\n\n\n\n
                                                          6. \u751f\u99d2\u82f1\u660e\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u9818\u57df\u306b\u304a\u3051\u308b\u96fb\u96e2\u7bb1\u8a08\u6e2c\uff1b\u96fb\u96e2\u7bb1\u3092\u4f7f\u7528\u3057\u3066\u3069\u306e\u3088\u3046\u306b\u8a08\u6e2c\u3055\u308c\u308b\u306e\uff1f\u304c\u3093\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u990a\u6210\u30d7\u30e9\u30f3\u7b2c 1 \u56de\u533b\u5b66\u7269\u7406\u30d9\u30fc\u30b7\u30c3\u30af\u30bb\u30df\u30f3\u30ca\u30fc\u30012018.3\uff08\u963f\u898b\uff09<\/li>\n\n\n\n
                                                          7. \u6e05\u6c34 \u8aa0.\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u30da\u30a4\u30b7\u30a7\u30f3\u30c8\u30fb\u30b1\u30a2\uff0e\u8328\u57ce\u770c\u7acb\u533b\u7642\u5927\u5b66 4 \u5e74\u8ab2\u7a0b\u30012017.7\uff08\u963f\u898b\uff09<\/li>\n\n\n\n
                                                          8. \u6e05\u6c34 \u8aa0.\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u30ea\u30b9\u30af\u8ad6\uff0e\u8328\u57ce\u770c\u7acb\u533b\u7642\u5927\u5b66 4 \u5e74\u8ab2\u7a0b\u30012017.7\uff08\u963f\u898b\uff09<\/li>\n\n\n\n
                                                          9. \u7be0\u7530\u548c\u54c9\uff0e\u6cbb\u7642\u8a08\u753b\u88c5\u7f6e\u306e\u57fa\u790e\u3068\u672a\u6765\uff5e\u6cbb\u7642\u8a08\u753b CT \u304a\u3088\u3073\u5404\u7a2e\u753b\u50cf\u306e\u54c1\u8cea\u7ba1\u7406\uff5e\uff0e\u95a2\u6771\u7532\u4fe1\u8d8a\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u5b66\u8853\u5927\u4f1a RTT \u8a8d\u8a3c\u6a5f\u69cb\u5171\u50ac\u30df\u30cb\u30de\u30e0\u30bb\u30df\u30ca\u30fc\u30012017.6\uff08\u9577\u91ce\uff09<\/li>\n\n\n\n
                                                          10. \u7be0\u7530\u548c\u54c9\uff0eBiological Target Volume : BTV \u306e\u73fe\u72b6\u3068\u672a\u6765\uff0e\u9577\u91ce\u770c\u653e\u5c04\u7dda\u6cbb\u7642\u6280\u8853\u7814\u7a76\u4f1a\u30012017.12\uff08\u9577\u91ce\uff09<\/li>\n\n\n\n
                                                          11. \u7be0\u7530\u548c\u54c9\uff0eVMAT \u306e\u81e8\u5e8a\uff0e\u5e73\u6210 29 \u5e74\u5ea6\u7b2c 4 \u56de\u95a2\u6771 RT \u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc\u30012017.12\uff08\u5b87\u90fd\u5bae\uff09<\/li>\n\n\n\n
                                                          12. \u7be0\u7530\u548c\u54c9\uff0eFilm Dosimetry \u5b9f\u8df5\uff0e\u8328\u57ce\u770c\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u4f1a\u6cbb\u7642\u6280\u8853\u30fb\u7269\u7406\u5206\u79d1\u4f1a\u30012018.1\uff08\u7b20\u9593\uff09<\/li>\n\n\n\n
                                                          13. \u7be0\u7530\u548c\u54c9\uff0e\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u6cbb\u7642\u3067 Functional Image \u306e\u679c\u305f\u3059\u5f79\u5272\uff0e\u30b7\u30fc\u30e1\u30f3\u30b9\uff06\u30d0\u30ea\u30a2\u30f3\u653e\u5c04\u7dda\u6cbb\u7642\u30b7\u30b9\u30c6\u30e0\u30bb\u30fc\u30eb\u30b9\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u30012018.3\uff08\u6771\u4eac\uff09<\/li>\n\n\n\n
                                                          14. \u7be0\u7530\u548c\u54c9\uff0e\u96fb\u96e2\u7bb1\u3067\u3069\u3093\u306a\u8a08\u6e2c\u304c\u3067\u304d\u308b\u304b\uff1f \u304c\u3093\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u990a\u6210\u30d7\u30e9\u30f3\u7b2c1\u56de\u533b\u5b66\u7269\u7406\u30d9\u30fc\u30b7\u30c3\u30af\u30bb\u30df\u30ca\u30fc\u30012018.3\uff08\u963f\u898b\uff09<\/li>\n<\/ol>\n\n\n\n

                                                            \u5e73\u621028\u5e74\u5ea6<\/h3>\n\n\n\n

                                                            \u3010\u8ad6\u6587\u3011<\/p>\n\n\n\n

                                                              \n
                                                            1. Ohba A, Kato K, Ito Y, Katada C, Ishiyama H, Yamamoto S, Ura T, Kodaira T, Kudo S, Tamaki Y. Chemoradiation therapy with docetaxel in elderly patients with stage II\/III esophageal cancer: A phase 2 trial. Advances in Radiation Oncology 1(4):230-236, 2016<\/li>\n\n\n\n
                                                            2. \u6c5f\u539f \u5a01\u3001\u5b89\u85e4 \u8b19\u3001\u5ddd\u539f\u6b63\u5bec\u3001\u5c3e\u5cf6 \u4ec1\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u9838\u90e8\u98df\u9053\u764c\u306b\u5bfe\u3059\u308b\u540c\u6642\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\uff0e\u81e8\u5e8a\u653e\u5c04\u7dda 61(8):1013-1017, 2016<\/li>\n<\/ol>\n\n\n\n

                                                              \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/p>\n\n\n\n

                                                                \n
                                                              1. \u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u4e09\u6d66\u822a\u661f\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u4e2d\u5ead\u7406\u3001\u8d64\u5ddd\u6075\u4e00\u90ce\u3001\u98ef\u7530\u4fee\u4e00\u3001\u9752\u6728\u8aa0\uff0e\u8328\u57ce\u770c\u7acb\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308b\u975e\u5bc6\u5c01\u7dda\u6e90\u6cbb\u7642\u306e\u73fe\u72b6\uff0e\u7b2c 12 \u56de\u8328\u57ce\u653e\u5c04\u7dda\u816b\u760d\u7814\u7a76\u30012016.10\uff08\u3072\u305f\u3061\u306a\u304b\uff09<\/li>\n\n\n\n
                                                              2. \u6e05\u6c34\u8aa0\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u751f\u99d2\u82f1\u660e\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u9752\u6728\u8aa0\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u5bae\u672c\u6075\u4e00\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\uff0e\u5916\u90e8\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u547c\u5438\u6027\u79fb\u52d5\u306e\u691c\u8a0e\uff0e\u7b2c 55 \u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012016.10\uff08\u5bcc\u5c71\uff09<\/li>\n\n\n\n
                                                              3. \u9752\u6728\u8aa0\u3001\u4e09\u5cf6\u6607\u3001\u624b\u585a\u82e5\u83dc\u3001\u7247\u7530\u6b63\u4e00\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u8077\u54e1\u306e\u653e\u5c04\u7dda\u88ab\u3070\u304f\u8efd\u6e1b\u306e\u305f\u3081\u306e\u53d6\u308a\u7d44\u307f\uff0e\u7b2c 55 \u56de\u5168\u56fd\u81ea\u6cbb\u4f53\u75c5\u9662\u5b66\u4f1a\u30012016.10\uff08\u5bcc\u5c71\uff09<\/li>\n\n\n\n
                                                              4. \u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u95a2\u91ce\u96c4\u592a\u3001\u5965\u6751\u654f\u4e4b\u3001\u6afb\u4e95\u82f1\u5e78\uff0e\u83cc\u72b6\u606f\u8089\u816b\u75c7\u306b\u5bfe\u3059\u308b\u5168\u8eab\u76ae\u819a\u96fb\u5b50\u7dda\u6cbb\u7642 -Stanford \u6cd5\u306b\u3088\u308b\u6cbb\u7642\u6210\u7e3e-\uff0e\u7b2c 54 \u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a 2016.10\uff08\u6a2a\u6d5c\uff09<\/li>\n\n\n\n
                                                              5. \u5b89\u85e4\u8b19\u3001\u5ddd\u539f\u6b63\u5bdb\u3001\u7389\u6728\u7fa9\u96c4\u3001\u6728\u66ae\u572d\u5b50\u3001\u4f0a\u5439\u53cb\u4e8c\u3001\u4e2d\u6751\u548c\u4eba\u3001\u9e7f\u6cbc\u9054\u54c9\u3001\u6c5f\u539f\u5a01\uff0e\u5b50\u5bae\u9838\u764c\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u6210\u7e3e\u3068\u305d\u306e\u4e88\u5f8c\u56e0\u5b50\uff0e\u7b2c 54 \u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012016.10\uff08\u6a2a\u6d5c\uff09<\/li>\n\n\n\n
                                                              6. \u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u7389\u6728\u7fa9\u96c4\u3001\u95a2\u91ce\u96c4\u592a\u3001\u65b0\u7530\u548c\u7bc4\u3001\u9752\u6728\u8aa0\u3001\u6e05\u6c34\u8aa0\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u6afb\u4e95\u82f1\u5e78\uff0e\u5b50\u5bae\u9838\u764c\u8853\u5f8c\u5f37\u5ea6\u5909\u8abf\u5f97\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u521d\u671f\u7d4c\u9a13\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 29 \u56de\u5b66\u8853\u5927\u4f1a\u30012016.11\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                                              7. \u95a2\u91ce\u96c4\u592a\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u65b0\u7530\u548c\u7bc4\u3001\u6e05\u6c34\u8aa0\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u9752\u6728\u8aa0\u3001\u6afb\u4e95\u82f1\u5e78\uff0e\u5f53\u9662\u306b\u304a\u3051\u308b\u5b50\u5bae\u9838\u764c\u306b\u5bfe\u3059\u308b\u753b\u50cf\u8a98\u5c0e\u5c0f\u7dda\u6e90\u6cbb\u7642\u306b\u304a\u3051\u308b\u6cbb\u7642\u52b9\u679c\u3068\u6709\u5bb3\u4e8b\u8c61\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 29 \u56de\u5b66\u8853\u5927\u4f1a\u30012016.11\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                                              8. \u5b89\u85e4\u8b19\u3001\u5ddd\u539f\u6b63\u5bec\u3001\u7389\u6728\u7fa9\u96c4\u3001\u6728\u66ae\u572d\u5b50\u3001\u4f0a\u5439\u53cb\u4e8c\u3001\u4e2d\u6751\u548c\u4eba\u3001\u9e7f\u6cbc\u9054\u54c9\u3001\u6c5f\u539f\u5a01\uff0e\u5b50\u5bae\u9838\u764c\u653e\u5c04\u7dda\u6cbb\u7642\u6210\u7e3e\u3068\u305d\u306e\u4e88\u5f8c\u56e0\u5b50\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 29 \u56de\u5b66\u8853\u5927\u4f1a\u30012016.11\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                                              9. \u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u95a2\u91ce\u96c4\u592a\u3001\u65b0\u7530\u548c\u7bc4\u3001\u9752\u6728\u8aa0\u3001\u6e05\u6c34\u8aa0\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u6797\u9756\u5b5d\u3001\u6afb\u4e95\u82f1\u5e78\uff0e\u5c40\u6240\u9032\u884c\u526f\u9f3b\u8154\u764c\u306b\u5bfe\u3059\u308b\u5f37\u5ea6\u5909\u8abf\u653e\u5c04\u7dda\u6cbb\u7642-6 \u4f8b\u306e\u77ed\u671f\u6cbb\u7642\u6210\u7e3e-\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 29 \u56de\u5b66\u8853\u5927\u4f1a\u30012016.11\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                                              10. \u6d77\u8001\u6839\u8056\u5b50\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u95a2\u91ce\u96c4\u592a\u3001\u65b0\u7530\u548c\u7bc4\u3001\u6e05\u6c34\u8aa0\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u5b8d\u5009\u512a\u5b50\u3001\u6c38\u5800\u7f8e\u5e78\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u4e73\u304c\u3093\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u770b\u8b77\u4ecb\u5165\u306e\u30bf\u30a4\u30df\u30f3\u30b0\u306b\u5199\u771f\u3092\u7528\u3044\u305f\u8a55\u4fa1\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 29 \u56de\u5b66\u8853\u5927\u4f1a\u30012016.11\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                                              11. \u6c5f\u539f\u5a01\u3001\u5b89\u85e4\u8b19\u3001\u5ddd\u539f\u6b63\u5bec\u3001\u5c3e\u5cf6\u4ec1\u3001\u7389\u6728\u7fa9\u96c4\uff0e\u8868\u5728\u98df\u9053\u764c\uff08T1N0M0\uff09\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6cbb\u7642\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c 29 \u56de\u5b66\u8853\u5927\u4f1a\u30012016.11\uff08\u4eac\u90fd\uff09<\/li>\n\n\n\n
                                                              12. \u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u95a2\u91ce\u96c4\u592a\u3001\u6e05\u5d8b\u8b77\u4e4b\u3001\u9234\u6728\u4e45\u53f2\u3001\u93d1\u6728\u5b5d\u4e4b\u3001\u6797\u9756\u5b5d\u3001\u5965\u6751\u654f\u4e4b\u3001\u77f3\u5ddd \u4ec1\u3001\u5927\u897f\u304b\u3088\u5b50\u3001\u6afb\u4e95\u82f1\u5e78\uff0e\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u8853\u5f8c\u30ea\u30f3\u30d1\u7bc0\u518d\u767a\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u610f\u7fa9\uff0e\u7b2c 57 \u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30012016.12\uff08\u798f\u5ca1\uff09<\/li>\n\n\n\n
                                                              13. \u751f\u99d2\u82f1\u660e\uff0e\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u653e\u5c04\u7dda\u7269\u7406\uff08\u533b\u5b66\u7269\u7406\u58eb\u306e\u8996\u70b9\u304b\u3089\uff09\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u7b2c63 \u56de\u95a2\u6771\u652f\u90e8\u7814\u7a76\u767a\u8868\u5927\u4f1a\u30012017.1\uff08\u5b87\u90fd\u5bae\uff09<\/li>\n\n\n\n
                                                              14. \u7389\u6728\u7fa9\u96c4\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u52d5\u5411\u3068\u8328\u57ce\u770c\u5185\u306e\u73fe\u72b6\uff0e\u7b2c 10 \u56de Quantum Medicine \u7814\u7a76\u4f1a\u30012017.2\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                              15. \u6e05\u6c34\u8aa0\uff0e\u5916\u90e8\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u547c\u5438\u505c\u6b62\u30fb\u547c\u5438\u540c\u671f\u306e\u691c\u8a0e\uff0e\u7b2c 9 \u56de\u8328\u57ce\u770c\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u4f1a\u653e\u5c04\u7dda\u6cbb\u7642\u6280\u8853\u7814\u7a76\u4f1a\u30012017.2\uff08\u3064\u304f\u3070\uff09<\/li>\n\n\n\n
                                                              16. \u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u4e09\u6d66\u822a\u661f\u3001\u9ad8\u6a4b\u90a6\u660e\u3001\u4e0a\u524d\u6cca\u529f\u3001\u5883\u4fee\u5e73\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u4e2d\u5ead\u7406\u3001\u8d64\u5ddd\u6075\u4e00\u90ce\u3001\u98ef\u7530\u4fee\u4e00\u3001\u9752\u6728\u8aa0\u3001\u5927\u7560\u9ad8\u5b50\uff0e\u7532\u72b6\u817a\u764c\u8853\u5f8c\u306e\u7532\u72b6\u817a\u30a2\u30d6\u30ec\u30fc\u30b7\u30e7\u30f3 -\u5c0e\u5165\u307e\u3067\u306e\u53d6\u308a\u7d44\u307f\u3068\u521d\u671f\u7d4c\u9a13\uff0e\u7b2c 26 \u56de\u8328\u57ce\u304c\u3093\u5b66\u4f1a\u30012017.2\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                              17. \u6e05\u6c34\u8aa0\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u751f\u99d2\u82f1\u660e\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u9752\u6728\u8aa0\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u5bae\u672c\u6075\u4e00\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\uff0e\u5916\u90e8\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u547c\u5438\u6027\u79fb\u52d5\u306e\u691c\u8a0e\uff0e\u7b2c 26 \u56de\u8328\u57ce\u304c\u3093\u5b66\u4f1a\u30012017.2\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                              18. \u9752\u6728\u8aa0\u3001\u5bae\u672c\u6075\u4e00\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u751f\u99d2\u82f1\u660e\u3001\u6e05\u6c34\u8aa0\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u65b0\u7530\u548c\u7bc4\u3001\u7389\u6728\u7fa9\u96c4\u3001\u5927\u91ce\u8c4a\u7136\u8cb4\u3001\u6d77\u8001\u6839\u8056\u5b50\u3001\u5b8d\u5009\u512a\u5b50\u3001\u7551\u5ca1\u6075\u7f8e\u5b50\u3001\u6c38\u5800\u7f8e\u5e78\u3001\u4e0a\u91ce\u771f\u6a39\uff0e\u65b0\u3057\u3044\u653e\u5c04\u7dda\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc\u958b\u8a2d\u306e\u9032\u6357\u306b\u3064\u3044\u3066\uff0e\u7b2c 26 \u56de\u8328\u57ce\u304c\u3093\u5b66\u4f1a\u30012017.2\uff08\u6c34\u6238\uff09<\/li>\n\n\n\n
                                                              19. \u751f\u99d2\u82f1\u660e\u3001\u6cb3\u5cf6\u901a\u4e45\u3001\u9752\u6728\u8aa0\u3001\u6e05\u6c34\u8aa0\u3001\u76f8\u6fa4\u5065\u592a\u90ce\u3001\u52a0\u85e4\u7f8e\u7a42\u3001\u65b0\u7530\u548c\u7bc4\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u71b1\u53ef\u5851\u6027\u30dc\u30fc\u30e9\u30b9\u306e\u7279\u6027\u3068\u81e8\u5e8a\u5c0e\u5165\u306b\u3064\u3044\u3066\uff0e\u7b2c 26 \u56de\u8328\u57ce\u304c\u3093\u5b66\u4f1a\u30012017.2\uff08\u6c34\u6238\uff09<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                                                                \u5e73\u621028\u5e74\u5ea6\uff5e\u4ee4\u548c5\u5e74\u5ea6 \u4ee4\u548c5\u5e74\u5ea6 \u3010\u8457\u66f8\u3011 \u3010\u8ad6\u6587\u3011 \u4ee4\u548c4\u5e74\u5ea6 \u3010\u539f\u8457\u3011 \u3010\u5b66\u4f1a\u767a\u8868\u3011 \u3010\u53d7\u8cde\u3011 \u3010\u5ea7\u9577\u3011 \u3010\u8b1b\u6f14\u3011 \u3010\u8b1b\u7fa9\u3011 \u4ee4\u548c3\u5e74\u5ea6 \u3010\u539f\u8457\u3011 \u3010\u5b66\u4f1a\u767a\u8868\u3011 \u3010\u5ea7\u9577\u3011 \u3010\u8b1b\u6f14\u3011 \u3010\u8b1b\u7fa9\u3011 \u4ee4\u548c2\u5e74\u5ea6 \u3010\u8ad6\u6587\u3011 […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":144,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","vk-ltc-link":"","vk-ltc-target":"0"},"class_list":["post-16970","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/comments?post=16970"}],"version-history":[{"count":2,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16970\/revisions"}],"predecessor-version":[{"id":20263,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/16970\/revisions\/20263"}],"up":[{"embeddable":true,"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/pages\/144"}],"wp:attachment":[{"href":"https:\/\/www.hospital.pref.ibaraki.jp\/chuo\/wp-json\/wp\/v2\/media?parent=16970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}